[
  {
    "id": 10,
    "user_query": "Name synonym of Acrokeratosis paraneoplastica.",
    "llama-2-7b-chat-hf_response": "Acrokeratosis paraneoplastica is also known as:\n* Acrokeratosis paraneoplastic\nNote: These terms are synonyms, and both terms refer to the same medical condition."
  },
  {
    "id": 47,
    "user_query": "Is Weaver syndrome similar to Sotos?",
    "llama-2-7b-chat-hf_response": "Weaver syndrome and Sotos syndrome are both rare genetic disorders that are characterized by overgrowth and developmental delays, but they have some differences in their clinical features and genetic causes.\nWeaver syndrome is caused by mutations in the PHLPP2 gene, which encodes a protein involved in the regulation of the PI3K/Akt signaling pathway. The main features of Weaver syndrome include:\n* Overgrowth (gigantism)\n* Developmental delays and intellectual disability\n* Distinctive facial features, such as a large head, prominent eyes, and a wide nasal bridge\n* Skeletal abnormalities, such as joint hypermobility and short stature\n* Cardiovascular problems, such as hypertension and cardiac defects\n* Increased risk of cancer\nSotos syndrome, on the other hand, is caused by mutations in the NSD1 gene, which encodes a protein involved in the regulation of chromatin remodeling and transcriptional elongation. The main features of Sotos syndrome include:\n* Overgrowth (gigantism)\n* Developmental delays and intellectual disability\n* Distinctive facial features, such as a large head, prominent eyes, and a wide nasal bridge\n* Skeletal abnormalities, such as joint hypermobility and short stature\n* Cardiovascular problems, such as hypertension and cardiac defects\n* Increased risk of cancer\nWhile both disorders share some similarities in terms of their clinical features, Weaver syndrome is generally considered to be a milder disorder compared to Sotos syndrome. Weaver syndrome typically has a more gradual onset of symptoms, and the overgrowth is less pronounced compared to Sotos syndrome. Additionally, the facial features of Weaver syndrome are less distinctive than those seen in Sotos syndrome.\nIn summary, while Weaver syndrome and Sotos syndrome share some similarities, they are distinct disorders with different genetic causes and clinical features."
  },
  {
    "id": 81,
    "user_query": "List the releases of JASPAR database",
    "llama-2-7b-chat-hf_response": "JASPAR (Junkunc Alignment of Sequence Protein Alignments) is a database of transcription factor binding site (TFBS) profiles for various organisms. Here are the releases of the JASPAR database:\n1. JASPAR Release 1 (1999): This was the first release of the JASPAR database, containing TFBS profiles for 14 organisms, including humans, mice, and yeast.\n2. JASPAR Release 2 (2002): This release added TFBS profiles for 11 additional organisms, including Drosophila and C. elegans.\n3. JASPAR Release 3 (2006): This release improved the quality of the TFBS profiles and added new organisms, including the zebrafish and the nematode Caenorhabditis elegans.\n4. JASPAR Release 4 (2010): This release included improved TFBS profiles for all organisms, as well as new features such as the ability to search for conserved TFBSs across multiple species.\n5. JASPAR Release 5 (2014): This release included improved TFBS profiles for all organisms, as well as new features such as the ability to search for TFBSs in non-coding RNA sequences.\n6. JASPAR Release 6 (2017): This release included improved TFBS profiles for all organisms, as well as new features such as the ability to search for TFBSs in the context of specific genomic features, such as gene deserts or enhancers.\n7. JASPAR Release 7 (2020): This is the latest release of the JASPAR database, which includes improved TFBS profiles for all organisms, as well as new features such as the ability to search for TFBSs in the context of specific epigenetic marks.\nIt's worth noting that the JASPAR database is constantly being updated and improved, so there may be additional releases beyond these listed here."
  },
  {
    "id": 99,
    "user_query": "What is the function of the viral KP4 protein?",
    "llama-2-7b-chat-hf_response": "The KP4 protein is a protein encoded by the KP4 gene in some viruses, including the poxvirus. The KP4 protein plays a role in the regulation of the viral genome replication and transcription, and is involved in the evasion of the host immune response. It can also interact with host cell factors and modulate their activity to promote viral replication."
  },
  {
    "id": 124,
    "user_query": "Is DITPA a thyroid hormone analog utilized in experimental and clinical studies",
    "llama-2-7b-chat-hf_response": "Yes, DITPA (N-[4-(5-Iodonaphthalene-1-yl)-2-methylphenyl]-5-iodo-2-pyrimidinone) is a thyroid hormone analog that has been utilized in both experimental and clinical studies. DITPA is a potent agonist of the thyroid hormone receptor (TR) and has been used to study the role of thyroid hormones in various physiological processes, including metabolism, growth, and development.\nIn experimental studies, DITPA has been used to investigate the mechanisms of thyroid hormone action, the regulation of gene expression, and the effects of thyroid hormone deficiency or excess on various tissues and organs. For example, DITPA has been used to study the effects of thyroid hormone deficiency on fetal development during pregnancy, the regulation of lipid metabolism, and the role of thyroid hormones in the regulation of immune function.\nIn clinical studies, DITPA has been used as a tool for the diagnosis and treatment of thyroid disorders, such as hypothyroidism and hyperthyroidism. DITPA has been shown to be effective in suppressing the production of thyroid hormones in patients with hyperthyroidism, and it has also been used to stimulate the production of thyroid hormones in patients with hypothyroidism.\nHowever, it is important to note that DITPA is a potent and highly specific agonist of the TR, and its use in humans is associated with potential side effects, such as hyperthyroidism, tachycardia, and palpitations. As a result, DITPA is typically used in clinical settings only under close medical supervision and as part of a comprehensive treatment plan for thyroid disorders."
  },
  {
    "id": 144,
    "user_query": "What is the COUGER tool?",
    "llama-2-7b-chat-hf_response": "COUGER (Comprehensive Upgrade of Genome-scale Regulatory Networks) is a tool used in bioinformatics for the comprehensive analysis and upgrade of genome-scale regulatory networks. It is designed to improve the accuracy and completeness of regulatory network models by integrating a wide range of data types, including gene expression profiles, protein-DNA interaction data, and genomic features. COUGER uses a Bayesian inference framework to integrate these data types and generate a more accurate and comprehensive model of the regulatory network. The tool can be used to study the regulation of gene expression in a variety of organisms, including bacteria, yeast, and humans."
  },
  {
    "id": 145,
    "user_query": "Are there drugs for Tick-borne Encephalitis?",
    "llama-2-7b-chat-hf_response": "Yes, there are drugs available for the treatment of tick-borne encephalitis (TBE). The most commonly used drugs are:\n1. Antiviral medications: Ribavirin, an antiviral drug, is the most commonly used treatment for TBE. It is effective in reducing the severity of symptoms and preventing complications.\n2. Corticosteroids: Corticosteroids, such as prednisone, are sometimes prescribed to reduce inflammation in the brain and alleviate symptoms.\n3. Antibiotics: In cases where TBE is caused by a bacterial infection, antibiotics such as doxycycline or azithromycin may be prescribed.\n4. Supportive care: Supportive care, such as rest, hydration, and pain management, is also important in managing TBE.\nIt's important to note that the best treatment approach for TBE may vary depending on the severity and location of the infection, as well as the individual patient's medical history and overall health. In some cases, a combination of these treatments may be used. Early diagnosis and treatment are critical in improving outcomes for patients with TBE."
  },
  {
    "id": 151,
    "user_query": "Which genome browser database for DNA shape annotations is available?",
    "llama-2-7b-chat-hf_response": "There are several genome browsers that provide DNA shape annotations, including:\n1. UCSC Genome Browser: The University of California, Santa Cruz (UCSC) Genome Browser provides DNA shape annotations using the Circos tool, which generates circular maps of genomic regions and their associated features.\n2. Ensembl Genome Browser: The Ensembl Genome Browser provides DNA shape annotations using the Circos tool, as well as other tools such as Bedtools and HISAT2.\n3. Genome Graph Explorer (GGE): GGE is a web-based genome browser that provides DNA shape annotations using a variety of tools, including Circos, Bedtools, and HISAT2.\n4. OpenGenomeBrowser (OGB): OGB is a web-based genome browser that provides DNA shape annotations using a variety of tools, including Circos, Bedtools, and HISAT2.\n5. Bioconductor: Bioconductor is a collection of R packages for genomics analysis, including several tools for DNA shape annotation, such as Circos, Bedtools, and HISAT2.\n6. G Browser: G Browser is a web-based genome browser that provides DNA shape annotations using a variety of tools, including Circos, Bedtools, and HISAT2.\n7. Genome Atlas (GAT): GAT is a web-based genome browser that provides DNA shape annotations using a variety of tools, including Circos, Bedtools, and HISAT2.\n8. Genomic Architecture: Genomic Architecture is a web-based genome browser that provides DNA shape annotations using a variety of tools, including Circos, Bedtools, and HISAT2.\n9. Chromatin Atlas (ChA): ChA is a web-based genome browser that provides DNA shape annotations using a variety of tools, including Circos, Bedtools, and HISAT2.\n10. Epigenome Atlas (EpiAtlas): EpiAtlas is a web-based genome browser that provides DNA shape annotations using a variety of tools, including Circos, Bedtools, and HISAT2.\nPlease note that this is not an exhaustive list, and there may be other genome browsers available that provide DNA shape annotations."
  },
  {
    "id": 174,
    "user_query": "Which syndromes are associated with mutations in the EZH2 gene?",
    "llama-2-7b-chat-hf_response": "The EZH2 gene has been associated with several syndromes, including:\n1. EP300-related syndrome: This is a rare genetic disorder characterized by developmental delays, intellectual disability, and a variety of physical abnormalities, including distinctive facial features and skeletal abnormalities.\n2. EZH2-related overgrowth syndrome: This is a rare genetic disorder characterized by excessive growth and development, as well as various other physical and developmental abnormalities.\n3. Horta-Hitzemethven syndrome: This is a rare genetic disorder characterized by developmental delays, intellectual disability, and a variety of physical abnormalities, including distinctive facial features and skeletal abnormalities.\n4. Cdkn2a-related overgrowth syndrome: This is a rare genetic disorder characterized by excessive growth and development, as well as various other physical and developmental abnormalities.\n5. Cdkn2a-related developmental disorder: This is a rare genetic disorder characterized by developmental delays and intellectual disability, as well as various other physical and developmental abnormalities.\nIt is important to note that mutations in the EZH2 gene can also occur sporadically, without a clear family history, in certain types of cancer, including lymphoma and leukemia."
  },
  {
    "id": 193,
    "user_query": "List human proteins that are subject to a dimer-to-tetramer transition.",
    "llama-2-7b-chat-hf_response": "There are several human proteins that are known to undergo a dimer-to-tetramer transition, including:\n1. p53: The tumor suppressor protein p53 is a well-known example of a protein that undergoes a dimer-to-tetramer transition. The p53 protein exists as a dimer in its inactive state, but upon DNA damage or other forms of cellular stress, it can transition to a tetrameric state, which is more active and capable of transcriptional activation.\n2. c-Myc: The c-Myc protein is a transcription factor that is involved in cellular proliferation, differentiation, and apoptosis. c-Myc exists as a dimer in its inactive state, but upon phosphorylation, it can transition to a tetrameric state, which is more active and capable of transcriptional activation.\n3. p73: The p73 protein is a tumor suppressor protein that is similar in structure and function to p53. Like p53, p73 exists as a dimer in its inactive state, but upon DNA damage or other forms of cellular stress, it can transition to a tetrameric state, which is more active and capable of transcriptional activation.\n4. STAT3: The STAT3 protein is a transcription factor that is involved in the regulation of inflammation and immune responses. STAT3 exists as a dimer in its inactive state, but upon phosphorylation, it can transition to a tetrameric state, which is more active and capable of transcriptional activation.\n5. FOXO1: The FOXO1 protein is a transcription factor that is involved in the regulation of metabolism, cellular stress responses, and longevity. FOXO1 exists as a dimer in its inactive state, but upon phosphorylation, it can transition to a tetrameric state, which is more active and capable of transcriptional activation.\n6. NF-κB: The NF-κB protein is a transcription factor that is involved in the regulation of inflammation and immune responses. NF-κB exists as a dimer in its inactive state, but upon phosph"
  },
  {
    "id": 210,
    "user_query": "Which protein has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein?",
    "llama-2-7b-chat-hf_response": "One protein that has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein is Bcl-2 (B-cell lymphoma 2)."
  },
  {
    "id": 218,
    "user_query": "Has vitamin D has been shown to reduce incidence of falls in older people in clinical trials?",
    "llama-2-7b-chat-hf_response": "Yes, several clinical trials have shown that vitamin D supplementation can reduce the incidence of falls in older people. Here are some examples:\n1. A 2012 Cochrane review of 14 randomized controlled trials found that vitamin D supplementation was associated with a significant reduction in the risk of falls in older adults (odds ratio 0.63, 95% CI 0.45-0.89).\n2. A 2013 meta-analysis of 17 randomized controlled trials found that vitamin D supplementation was associated with a significant reduction in the risk of falls in older adults (odds ratio 0.67, 95% CI 0.53-0.85).\n3. A 2016 randomized controlled trial found that vitamin D supplementation (2000 IU/day) for 12 months reduced the incidence of falls by 43% in older adults with a history of falls (n=137).\n4. A 2017 randomized controlled trial found that vitamin D supplementation (1000 IU/day) for 12 months reduced the incidence of falls by 37% in older adults with a history of falls (n=107).\nIt is important to note that the optimal dose and duration of vitamin D supplementation for fall prevention is still unclear and may vary depending on individual factors such as age, sex, and baseline vitamin D status. Additionally, while vitamin D supplementation has been shown to reduce the incidence of falls, it may not necessarily eliminate falls entirely, and other factors such as exercise, balance training, and environmental modifications should also be considered in fall prevention strategies."
  },
  {
    "id": 222,
    "user_query": "Is there any association between Jarid2 and miR-155 in Th17 cells?",
    "llama-2-7b-chat-hf_response": "Yes, there is an association between Jarid2 and miR-155 in Th17 cells. Jarid2 (also known as KAT2A) is a histone methyltransferase that is involved in the regulation of chromatin structure and gene expression, particularly in the context of T cell differentiation and function. miR-155 is a microRNA that is known to play a role in the regulation of Th17 cell differentiation and function, and has been implicated in a number of autoimmune diseases.\nStudies have shown that Jarid2 and miR-155 are co-regulated in Th17 cells, and that Jarid2 is required for the proper expression of miR-155. Specifically, Jarid2 has been shown to bind to the promoter region of the miR-155 gene and to mediate its transcriptional activation.\nFurthermore, miR-155 has been shown to target and regulate the expression of genes involved in Th17 cell differentiation and function, including the transcription factor retinoic acid-related orphan receptor gamma t (ROR-γt), which is a key regulator of Th17 cell differentiation.\nOverall, the association between Jarid2 and miR-155 in Th17 cells suggests that these two molecules may play a coordinated role in regulating Th17 cell differentiation and function, and may be potential targets for the development of new therapies for autoimmune diseases."
  },
  {
    "id": 224,
    "user_query": "How many genes does the human hoxD cluster contain?",
    "llama-2-7b-chat-hf_response": "The human HoxD cluster contains 9 genes: Hoxd1, Hoxd2, Hoxd3, Hoxd4, Hoxd5, Hoxd6, Hoxd7, Hoxd8, and Hoxd9."
  },
  {
    "id": 268,
    "user_query": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?",
    "llama-2-7b-chat-hf_response": "Casein Kinase 1 (CK1) is a serine/threonine protein kinase that phosphorylates a variety of substrates in cells. The phosphorylation consensus motifs for CK1 are:\n1. Ser/Thr-Pro-Pro-X-X-Ser/Thr (where X is any amino acid)\nThis motif is recognized by the catalytic subunit of CK1 and is found in the phosphorylation sites of many CK1 targets.\n2. Ser/Thr-Pro-X-X-Ser/Thr (where X is any amino acid)\nThis motif is also recognized by the catalytic subunit of CK1 and is found in the phosphorylation sites of some CK1 targets.\n3. Ser/Thr-Gly-X-X-Ser/Thr (where X is any amino acid)\nThis motif is recognized by the regulatory subunit of CK1 and is found in the phosphorylation sites of some CK1 targets.\n4. Thr-X-X-Ser/Thr (where X is any amino acid)\nThis motif is recognized by the catalytic subunit of CK1 and is found in the phosphorylation sites of some CK1 targets.\nIt's worth noting that the consensus motifs for CK1 are not fixed and can vary depending on the specific substrate and context in which the kinase is active. Additionally, CK1 can also phosphorylate other sites on proteins that do not contain these consensus motifs."
  },
  {
    "id": 305,
    "user_query": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?",
    "llama-2-7b-chat-hf_response": "The ASPH (aspartate beta-hydroxylase) gene in humans encodes several different proteins/isoforms, including:\n1. Aspartate beta-hydroxylase (ABH): This is the main isoform of the enzyme, which is involved in the biosynthesis of the neurotransmitter serotonin.\n2. Tissue inhibitor of metalloproteinases 1 (TIMP1): This isoform is a potent inhibitor of matrix metalloproteinases (MMPs), which are enzymes involved in the breakdown of the extracellular matrix.\n3. Matrix metalloproteinase 9 (MMP9): This isoform is a member of the MMP family, which are involved in the breakdown of the extracellular matrix and play a role in various physiological processes, including tissue remodeling and inflammation.\n4. Osteopontin (OPN): This isoform is a secreted protein that plays a role in the regulation of cellular responses to inflammation and tissue repair.\n5. Protein disulfide isomerase (PDI): This isoform is involved in the folding and stability of proteins, particularly those that contain disulfide bonds.\n6. Glutathione S-transferase (GST): This isoform is involved in the detoxification of harmful substances in the body, such as drugs and environmental toxins, by conjugating them with glutathione.\n7. Carbonic anhydrase (CA): This isoform is involved in the regulation of pH levels in the body, particularly in the brain and kidneys.\n8. Phospholipase A2 (PLA2): This isoform is involved in the breakdown of phospholipids in the body, which can lead to the production of inflammatory mediators.\n9. 5-Lipoxygenase (5-LO): This isoform is involved in the production of leukotrienes, which are pro-inflammatory mediators that play a role in various inflammatory responses.\n10. Fibrinogen-like protein 1 (FGL1): This is"
  },
  {
    "id": 330,
    "user_query": "When was empagliflozin FDA approved?",
    "llama-2-7b-chat-hf_response": "Empagliflozin was FDA approved in 2014. It was approved by the U.S. Food and Drug Administration (FDA) on June 28, 2014, for the treatment of type 2 diabetes."
  },
  {
    "id": 350,
    "user_query": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?",
    "llama-2-7b-chat-hf_response": "Loss of the protein Lon1 in the plant Arabidopsis thaliana has been shown to have several phenotypic effects, including:\n1. Increased sensitivity to oxidative stress: Lon1 plays a role in protecting against oxidative damage by scavenging reactive oxygen species (ROS). Mutants lacking Lon1 are more sensitive to oxidative stress, as evidenced by increased leaf chlorosis and reduced seedling growth.\n2. Altered cell wall structure and function: Lon1 is involved in the biosynthesis of cell wall components, such as cellulose and hemicellulose. Mutants lacking Lon1 have altered cell wall structure and function, leading to changes in plant growth and development.\n3. Impaired root development: Lon1 is expressed in the root meristem and plays a role in regulating root growth and differentiation. Mutants lacking Lon1 have reduced root length and altered root architecture.\n4. Delayed flowering time: Lon1 regulates floral transition in Arabidopsis, and mutants lacking Lon1 have a delayed flowering time.\n5. Reduced seed production: Lon1 is involved in the regulation of seed size and number. Mutants lacking Lon1 have reduced seed production and altered seed size.\n6. Changes in hormone biosynthesis and signaling: Lon1 regulates the biosynthesis of plant hormones, such as auxin and ethylene. Mutants lacking Lon1 have altered hormone levels and signaling, leading to changes in plant growth and development.\n7. Altered defense responses: Lon1 is involved in the regulation of defense responses to pathogens and abiotic stressors. Mutants lacking Lon1 have reduced defense responses and are more susceptible to pathogens.\n8. Changes in transcriptional regulation: Lon1 regulates the expression of a number of genes involved in various cellular processes. Mutants lacking Lon1 have altered gene expression profiles, leading to changes in plant growth and development."
  },
  {
    "id": 409,
    "user_query": "Does a linker histone exist in the yeast genome?",
    "llama-2-7b-chat-hf_response": "Yes, a linker histone called H3.3 exists in the yeast genome. H3.3 is a variant of the histone H3 protein that is specifically enriched at the centromeres and telomeres of yeast chromosomes, where it plays a role in the maintenance of chromosome stability and segregation during cell division."
  },
  {
    "id": 418,
    "user_query": "Is there evidence that tomato juice lowers cholesterol levels?",
    "llama-2-7b-chat-hf_response": "Yes, there is some evidence to suggest that tomato juice may help lower cholesterol levels.\nOne study published in the Journal of Nutrition found that drinking 8 ounces of tomato juice daily for 12 weeks significantly reduced total cholesterol and LDL (bad) cholesterol levels in healthy adults. Another study published in the European Journal of Clinical Nutrition found that drinking 100 mL of tomato juice daily for 12 weeks reduced LDL cholesterol levels by 10% in patients with mild hypercholesterolemia.\nIt is thought that the lycopene and other antioxidants in tomato juice may help reduce cholesterol levels by inhibiting the absorption of dietary cholesterol in the gut, increasing the excretion of bile, and reducing the activity of enzymes involved in cholesterol synthesis.\nHowever, it's important to note that these studies were small and more research is needed to confirm these findings and establish the optimal dosage and duration of tomato juice consumption for cholesterol lowering effects. Additionally, tomato juice is just one part of a healthy diet and lifestyle that can help manage cholesterol levels, and it should not be relied upon as the sole treatment for high cholesterol."
  },
  {
    "id": 472,
    "user_query": "How do Hsp70 and Hsp110 affect mRNA stability?",
    "llama-2-7b-chat-hf_response": "Hsp70 and Hsp110 are protein chaperones that play a crucial role in regulating mRNA stability by modulating the translation and degradation of mRNAs.\nHsp70:\n* Hsp70 binds to the 3' untranslated region (UTR) of target mRNAs and protects them from degradation by the 5' to 3' exonuclease activity of the RNA-induced silencing complex (RISC).\n* Hsp70 also promotes the translation of mRNAs by blocking the activity of the RNA-binding protein, KHDRBS1, which is involved in the degradation of mRNAs.\n* Overexpression of Hsp70 has been shown to increase mRNA stability by reducing the degradation of mRNAs, leading to increased protein expression.\nHsp110:\n* Hsp110 is a molecular chaperone that specifically binds to the 3' UTR of mRNAs and protects them from degradation by the RISC complex.\n* Hsp110 also promotes the translation of mRNAs by blocking the activity of the RNA-binding protein, KHDRBS1, which is involved in the degradation of mRNAs.\n* Overexpression of Hsp110 has been shown to increase mRNA stability by reducing the degradation of mRNAs, leading to increased protein expression.\nIn summary, both Hsp70 and Hsp110 play a crucial role in regulating mRNA stability by protecting mRNAs from degradation and promoting their translation, leading to increased protein expression."
  },
  {
    "id": 481,
    "user_query": "Which deiodinases are present in skeletal  muscle?",
    "llama-2-7b-chat-hf_response": "Deiodinases are enzymes that play a crucial role in regulating thyroid hormone metabolism. In skeletal muscle, there are two types of deiodinases present:\n1. Deiodinase type 1 (D1): D1 is the primary deiodinase isoform in skeletal muscle and is responsible for converting T4 to T3. T3 is the active form of thyroid hormone that plays a key role in regulating muscle contraction and metabolism.\n2. Deiodinase type 2 (D2): D2 is less abundant in skeletal muscle compared to D1, but it also plays a role in converting T4 to T3.\nBoth D1 and D2 deiodinases are essential for maintaining proper thyroid hormone levels in skeletal muscle, which is critical for muscle function and metabolism."
  },
  {
    "id": 534,
    "user_query": "List inflammatory caspase proteins?",
    "llama-2-7b-chat-hf_response": "Inflammatory caspase proteins are a group of proteins that play a role in the regulation of inflammation. Here are some examples of inflammatory caspase proteins:\n1. Caspase-1: Also known as interleukin-1β (IL-1β) converting enzyme (ICE), caspase-1 is a key regulator of inflammation and plays a role in the processing and activation of pro-inflammatory cytokines such as IL-1β and tumor necrosis factor-α (TNF-α).\n2. Caspase-3: Also known as caspase-8, this enzyme is involved in the regulation of apoptosis (programmed cell death) and inflammation. It plays a role in the activation of pro-inflammatory cytokines such as IL-1β and TNF-α.\n3. Caspase-7: This enzyme is involved in the regulation of inflammation and immune responses, and plays a role in the activation of pro-inflammatory cytokines such as IL-1β and TNF-α.\n4. Caspase-9: Also known as caspase-3-like protease, this enzyme is involved in the regulation of apoptosis and inflammation. It plays a role in the activation of pro-inflammatory cytokines such as IL-1β and TNF-α.\n5. Caspase-12: Also known as inflammatory caspase-12 (ICasp12), this enzyme is involved in the regulation of inflammation and immune responses. It plays a role in the activation of pro-inflammatory cytokines such as IL-1β and TNF-α.\n6. Caspase-13: Also known as cytokine-induced ICE-like protease (CYCLE), this enzyme is involved in the regulation of inflammation and immune responses. It plays a role in the activation of pro-inflammatory cytokines such as IL-1β and TNF-α.\n7. Caspase-14: Also known as interleukin-1β converting enzyme ("
  },
  {
    "id": 579,
    "user_query": "Is there any link between the aurora B kinase and the polycomb protein ring1B?",
    "llama-2-7b-chat-hf_response": "Yes, there is a link between Aurora B kinase and the polycomb protein Ring1B. Ring1B is a member of the polycomb repressive complex 2 (PRC2) and is involved in the regulation of gene expression, particularly during cell division. Aurora B kinase, on the other hand, is a serine/threonine kinase that plays a critical role in the proper separation of chromosomes during mitosis and meiosis.\nStudies have shown that Ring1B and Aurora B kinase interact and are involved in the regulation of each other's functions. For example, Ring1B has been shown to phosphorylate and activate Aurora B kinase, which is necessary for proper chromosome separation during cell division. Additionally, Aurora B kinase has been shown to regulate the localization and activity of Ring1B, particularly during meiosis.\nIn summary, there is a direct link between Aurora B kinase and Ring1B, and they work together to regulate various cellular processes, including chromosome separation and gene expression, during cell division."
  },
  {
    "id": 597,
    "user_query": "What are the most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates?",
    "llama-2-7b-chat-hf_response": "Non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates are short sequences that are not present in the consensus splice site sequences but are still recognized by the splicing machinery. Here are some of the most frequent non-canonical sequence motifs found in vertebrates:\nDonor splice sites:\n1. GU-rich sequences: Non-canonical donor splice sites often contain GU-rich sequences, which are rich in guanine and uridine nucleotides. These sequences can be recognized by the splicing machinery and can lead to the inclusion of intron sequences in the final mRNA.\n2. AU-rich sequences: Some non-canonical donor splice sites contain AU-rich sequences, which are rich in adenine and uridine nucleotides. These sequences can also be recognized by the splicing machinery and can lead to the inclusion of intron sequences.\n3. GT-rich sequences: Some non-canonical donor splice sites contain GT-rich sequences, which are rich in guanine and thymine nucleotides. These sequences can be recognized by the splicing machinery and can lead to the inclusion of intron sequences.\nAcceptor splice sites:\n1. AG/GC-rich sequences: Non-canonical acceptor splice sites often contain AG/GC-rich sequences, which are rich in adenine and guanine or cytosine and guanine nucleotides. These sequences can be recognized by the splicing machinery and can lead to the inclusion of intron sequences in the final mRNA.\n2. UG-rich sequences: Some non-canonical acceptor splice sites contain UG-rich sequences, which are rich in uridine and guanine nucleotides. These sequences can also be recognized by the splicing machinery and can lead to the inclusion of intron sequences.\n3. AU-rich sequences: Some non-canonical acceptor splice sites contain AU-rich sequences, which are rich in adenine and uridine nucleotides. These sequences can also be recognized by the splicing machinery and can lead to the inclusion of intron sequences.\nIt's worth"
  },
  {
    "id": 629,
    "user_query": "Which event results in the acetylation of S6K1?",
    "llama-2-7b-chat-hf_response": "The activation of mTOR (mechanistic target of rapamycin) signaling pathway results in the acetylation of S6K1 (serine/threonine kinase 1)."
  },
  {
    "id": 632,
    "user_query": "What is the cause of episodic ataxia type 6?",
    "llama-2-7b-chat-hf_response": "Episodic ataxia type 6 (EA6) is a rare genetic disorder that is caused by mutations in the CACNA1A gene. The CACNA1A gene encodes a subunit of the calcium channel alpha-1A subunit, which is involved in the regulation of neuronal excitability and synaptic transmission. Mutations in the CACNA1A gene lead to a loss of function of the calcium channel, resulting in an imbalance in the excitation and inhibition of neurons, leading to the characteristic episodes of ataxia, seizures, and other neurological symptoms associated with EA6."
  },
  {
    "id": 646,
    "user_query": "Are chromomethylases present in animal genomes?",
    "llama-2-7b-chat-hf_response": "Yes, chromomethylases are present in animal genomes. Chromomethylases are enzymes that modify chromatin structure by adding methyl groups to histone proteins, and they play important roles in regulating chromatin dynamics and gene expression in both prokaryotes and eukaryotes.\nIn animals, chromomethylases are involved in various cellular processes, including gene expression, DNA repair, and cell fate determination. For example, the enzyme G9a (also known as KMT1A) is a histone methyltransferase that is known to be involved in the regulation of gene expression, cell fate determination, and DNA repair in animals. Similarly, the enzyme SUV39H1 is a histone methyltransferase that is involved in the regulation of gene expression and chromatin structure in animals.\nIn addition, chromomethylases have been implicated in a variety of animal diseases, including cancer and neurological disorders. For example, altered expression of chromomethylases has been observed in various types of cancer, and it is thought to play a role in the development and progression of cancer.\nOverall, chromomethylases are an important class of enzymes that play a central role in regulating chromatin dynamics and gene expression in animal genomes."
  },
  {
    "id": 650,
    "user_query": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor",
    "llama-2-7b-chat-hf_response": "Here are some popular packages in R/Bioconductor for transcription factor binding site (TFBS) analysis:\n1. ChIPseek: This package uses a Bayesian approach to predict TFBSs in chromatin immunoprecipitation (ChIP) sequencing (ChIP-seq) data. It can also identify potential TFs and their binding motifs.\n2. HISAT2: This package is a part of the HISAT2 ChIP-seq pipeline, which can perform TFBS prediction, as well as other downstream analyses such as peak calling and motif analysis.\n3. DeepBind: This package uses a deep learning approach to predict TFBSs in ChIP-seq data. It can also predict the binding affinity and specificity of TFs.\n4. Prognosticate: This package uses a Bayesian approach to predict TFBSs in ChIP-seq data and also predicts the functional consequences of TF binding.\n5. TFBS-Pro: This package uses a machine learning approach to predict TFBSs in ChIP-seq data. It can also predict the binding affinity and specificity of TFs.\n6. ChromHMM: This package uses a hidden Markov model (HMM) to predict TFBSs in ChIP-seq data. It can also predict the binding affinity and specificity of TFs.\n7. CISTrome: This package uses a Bayesian approach to predict TFBSs in ChIP-seq data and also predicts the functional consequences of TF binding.\n8. PeakSeq: This package uses a Bayesian approach to predict TFBSs in ChIP-seq data and also predicts the binding affinity and specificity of TFs.\n9. TFBS-predictor: This package uses a machine learning approach to predict TFBSs in ChIP-seq data.\n10. TFSEARCH: This package uses a combination of machine learning and statistical methods to predict TFBSs in ChIP-seq data.\nPlease note that this is not an exhaustive list, and there are many other packages available in R/Bioconductor for TFBS analysis. The choice of package will depend on the specific requirements of the analysis and the research question being addressed."
  },
  {
    "id": 721,
    "user_query": "List clinical trials for prevention of sarcopenia",
    "llama-2-7b-chat-hf_response": "Here are some clinical trials related to the prevention of sarcopenia:\n1. \"Exercise and Nutrition Interventions to Prevent Sarcopenia in Older Adults: A Systematic Review and Meta-Analysis\" (2020) - This clinical trial aimed to evaluate the effectiveness of exercise and nutrition interventions in preventing sarcopenia in older adults.\n2. \"Effects of Resistance Training on Sarcopenia in Older Adults: A Systematic Review and Meta-Analysis\" (2019) - This clinical trial examined the effects of resistance training on sarcopenia in older adults.\n3. \"Nutritional Interventions to Prevent or Treat Sarcopenia: A Systematic Review\" (2019) - This clinical trial reviewed the effectiveness of various nutritional interventions in preventing or treating sarcopenia.\n4. \"Effects of Omega-3 Fatty Acid Supplementation on Sarcopenia in Older Adults: A Systematic Review and Meta-Analysis\" (2019) - This clinical trial investigated the effects of omega-3 fatty acid supplementation on sarcopenia in older adults.\n5. \"The Effects of Vitamin D and Omega-3 Fatty Acid Supplementation on Sarcopenia in Older Adults: A Randomized Controlled Trial\" (2018) - This clinical trial evaluated the effects of vitamin D and omega-3 fatty acid supplementation on sarcopenia in older adults.\n6. \"Resistance Training and Nutritional Interventions to Prevent Sarcopenia in Older Adults: A Randomized Controlled Trial\" (2018) - This clinical trial examined the effects of resistance training and nutritional interventions on sarcopenia in older adults.\n7. \"The Effects of Tai Chi Exercise on Sarcopenia in Older Adults: A Randomized Controlled Trial\" (2018) - This clinical trial investigated the effects of tai chi exercise on sarcopenia in older adult"
  },
  {
    "id": 722,
    "user_query": "Which is the database of molecular recognition features in membrane proteins?",
    "llama-2-7b-chat-hf_response": "There are several databases of molecular recognition features in membrane proteins, but some of the most well-known and widely used include:\n1. The Membrane Protein Database (MPD): This database contains a collection of structurally and functionally annotated membrane protein sequences, including information on their membrane-spanning segments, transmembrane helices, and intracellular and extracellular domains.\n2. The Protein Data Bank (PDB): This database contains a large collection of 3D structures of proteins, including membrane proteins, and provides information on their molecular recognition features, such as binding sites, active sites, and binding interactions.\n3. The Membrane Protein Structural Database (MuSiC): This database contains a collection of 3D structures of membrane proteins, along with information on their membrane-spanning segments, transmembrane helices, and intracellular and extracellular domains.\n4. The INTREPID database: This database contains a collection of membrane protein structures and their associated functional data, including information on their molecular recognition features, such as binding sites, active sites, and binding interactions.\n5. The Membrane Protein Interaction Database (MPI-db): This database contains a collection of interactions between membrane proteins and other proteins, including information on the binding sites and the functional implications of these interactions.\n6. The Protein-Ligand Interaction Database (PLID): This database contains a collection of interactions between proteins and ligands, including information on the binding sites and the functional implications of these interactions.\n7. The Membrane Protein-Ligand Interaction Database (MPLI): This database contains a collection of interactions between membrane proteins and ligands, including information on the binding sites and the functional implications of these interactions.\n8. The Membrane Protein-Protein Interaction Database (MPPI): This database contains a collection of interactions between membrane proteins and other proteins, including information on the binding sites and the functional implications of these interactions.\nThese databases provide valuable information on the molecular recognition features of membrane proteins, which can be used to understand their function and to design drugs that target these proteins."
  },
  {
    "id": 745,
    "user_query": "Is rivaroxaban metabolized in kidneys?",
    "llama-2-7b-chat-hf_response": "Yes, rivaroxaban is metabolized in the kidneys. Rivaroxaban is metabolized by the liver and kidneys through the cytochrome P450 (CYP) enzyme system, with the main metabolic pathway involving the CYP3A4 enzyme. The kidneys play a significant role in the elimination of rivaroxaban, as they are responsible for excreting the drug and its metabolites in the urine. Therefore, renal impairment can affect the pharmacokinetics and pharmacodynamics of rivaroxaban, leading to changes in its efficacy and safety."
  },
  {
    "id": 763,
    "user_query": "Which genes are regulated by TRalpha2  in the heart?",
    "llama-2-7b-chat-hf_response": "TRalpha2 is a subtype of the retinoic acid receptor (RAR) family of nuclear receptors, which play a crucial role in regulating gene expression in the heart. Studies have shown that TRalpha2 regulates the expression of several genes involved in cardiac development, function, and disease. Some of the genes known to be regulated by TRalpha2 in the heart include:\n1. Cardiac troponin I (TNNI): TRalpha2 regulates the expression of TNNI, a key contractile protein in the heart.\n2. Brain natriuretic peptide (BNP): TRalpha2 regulates the expression of BNP, a hormone that plays a role in cardiac remodeling and failure.\n3. GATA4: TRalpha2 regulates the expression of GATA4, a transcription factor that is important for cardiac development and function.\n4. Nkx2.5: TRalpha2 regulates the expression of Nkx2.5, a transcription factor that is important for cardiac development and differentiation.\n5. Mef2c: TRalpha2 regulates the expression of Mef2c, a transcription factor that is important for cardiac hypertrophy and adaptation to stress.\n6. Atrial natriuretic peptide (ANP): TRalpha2 regulates the expression of ANP, a hormone that plays a role in cardiac remodeling and failure.\n7. Bcl-2 family members: TRalpha2 regulates the expression of Bcl-2 family members, such as Bax and Bcl-xL, which play a role in regulating apoptosis and cardiac function.\n8. Fibrinolytic genes: TRalpha2 regulates the expression of genes involved in fibrinolysis, such as tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1), which play a role in regulating cardiac remodeling and failure.\nThese genes are just a few examples of the many genes that are regulated by TRalpha2 in the heart. Dysregulation of these genes has been implicated in a variety of cardiac diseases, including heart failure, hypertension, and arrhyth"
  },
  {
    "id": 786,
    "user_query": "List available biomedical question answering systems.",
    "llama-2-7b-chat-hf_response": "Here are some available biomedical question answering systems:\n1. PubMed: PubMed is a free database of biomedical literature maintained by the National Library of Medicine. It indexes over 29 million journal articles and other publications, and provides a question answering system that allows users to search for answers to biomedical questions.\n2. Biomedical Informatics Research Network (BIRN): BIRN is a question answering system that uses natural language processing and machine learning techniques to answer biomedical questions. It covers a wide range of topics in biomedicine and has been trained on a large corpus of biomedical literature.\n3. BioPortal: BioPortal is a question answering system developed by the National Center for Biotechnology Information (NCBI). It uses a combination of natural language processing and machine learning techniques to answer biomedical questions, and provides access to a wide range of biomedical databases and resources.\n4. Entrez: Entrez is a question answering system developed by the National Library of Medicine. It indexes a wide range of biomedical databases, including PubMed, GenBank, and Protein Data Bank, and provides a unified search interface for accessing these resources.\n5. Biomedical Information Retrieval System (BIRS): BIRS is a question answering system developed by the University of California, San Diego. It uses natural language processing and machine learning techniques to answer biomedical questions, and provides access to a wide range of biomedical databases and resources.\n6. Biomedical Question Answering System (BQAS): BQAS is a question answering system developed by the University of Texas Southwestern Medical Center. It uses natural language processing and machine learning techniques to answer biomedical questions, and provides access to a wide range of biomedical databases and resources.\n7. Biomedical Natural Language Processing (BioNLP) System: BioNLP is a question answering system developed by the University of Colorado Boulder. It uses natural language processing techniques to analyze biomedical text and extract relevant information, and can answer a wide range of biomedical questions.\n8. Biomedical Text Mining (BTM) System: BTM is a question answering system developed by the University of California, Los Angeles. It uses natural language processing and machine learning techniques to analyze biomedical text and extract relevant information, and can answer a wide range of bi"
  },
  {
    "id": 794,
    "user_query": "Which trancription factor activates the betalain pathway?",
    "llama-2-7b-chat-hf_response": "The transcription factor that activates the bethanechol pathway is ABSCISIC ACID INSENSITIVE 3 (ABI3)."
  },
  {
    "id": 883,
    "user_query": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?",
    "llama-2-7b-chat-hf_response": "There are several technologies that are commonly used for the enrichment of phosphorylated peptides in global quantitative phosphoproteomic analyses. Here are some of the preferred technologies:\n1. TiO2-based enrichment: TiO2 is a common matrix used for phosphoprotein enrichment due to its high affinity for phosphate groups. Phosphorylated peptides are captured onto the TiO2 surface, followed by washing and elution of non-phosphorylated peptides.\n2. IMAC (Immobilized Metal Affinity Chromatography): IMAC is a widely used method for phosphoprotein enrichment, which utilizes metal ions (e.g., Ni2+) to bind phosphorylated peptides. The phosphorylated peptides are immobilized on the metal ion matrix, while non-phosphorylated peptides are washed away.\n3. Cation exchange chromatography: Cation exchange chromatography is a versatile technique that can be used for the enrichment of phosphorylated peptides based on their charge. Phosphorylated peptides are exchanged for cations, such as ammonium ions, and then separated based on their charge.\n4. Hydrophilic interaction liquid chromatography (HILIC): HILIC is a method that separates peptides based on their hydrophilicity. Phosphorylated peptides, which are more hydrophilic than non-phosphorylated peptides, are enriched using HILIC chromatography.\n5. Reversed-phase HPLC: Reversed-phase HPLC is a widely used technique for separating peptides based on their hydrophobicity. Phosphorylated peptides are enriched by binding to a hydrophobic stationary phase, while non-phosphorylated peptides are washed away.\n6. Micro-columns: Micro-columns are small columns with a small diameter, typically in the range of 10-50 μm. They are used for enriching phosphorylated peptides based on their size, which is advantageous for studying post"
  },
  {
    "id": 901,
    "user_query": "Which disorder is rated by Palmini classification?",
    "llama-2-7b-chat-hf_response": "Palmini classification is used to rate the severity of a genetic disorder called Fabry disease."
  },
  {
    "id": 905,
    "user_query": "Are viruses involved in the etiology of human subacute thyroiditis?",
    "llama-2-7b-chat-hf_response": "Yes, some viruses have been implicated in the etiology of human subacute thyroiditis. Subacute thyroiditis is an inflammatory condition that affects the thyroid gland and is characterized by the sudden onset of symptoms such as fever, pain in the neck, and difficulty swallowing. While the exact cause of subacute thyroiditis is not fully understood, some studies have suggested that viral infections may play a role in its development.\nOne of the most well-known viruses associated with subacute thyroiditis is the thyroid gland-specific virus, TGV (Thyroid Gland Virus). TGV is a double-stranded RNA virus that is known to infect the thyroid gland and has been linked to the development of subacute thyroiditis in some studies.\nOther viruses that have been implicated in the etiology of subacute thyroiditis include:\n1. Herpesvirus: Herpesviruses, such as HSV (Herpes Simplex Virus) and HPV (Human Papillomavirus), have been shown to infect the thyroid gland and may contribute to the development of subacute thyroiditis.\n2. Adenovirus: Adenoviruses are known to infect the thyroid gland and have been linked to the development of subacute thyroiditis in some studies.\n3. Respiratory viruses: Respiratory viruses, such as influenza and respiratory syncytial virus (RSV), have been implicated in the development of subacute thyroiditis in some cases.\n4. Enteroviruses: Enteroviruses, such as Coxsackievirus and Enterovirus, have been linked to the development of subacute thyroiditis in some studies.\nIt is important to note that the exact role of viruses in the development of subacute thyroiditis is still being researched and debated, and more studies are needed to fully understand the relationship between viruses and this condition. However, viral infections are thought to play a role in the pathogenesis of subacute thyroiditis, and further research may lead to the development of new diagnostic and therapeutic strategies for this condition."
  },
  {
    "id": 963,
    "user_query": "Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?",
    "llama-2-7b-chat-hf_response": "Yes, STAT3 (Signal Transducer and Activator of Transcription 3) is involved in EIF2AK2-dependent suppression of autophagy. EIF2AK2 (Eukaryotic Translation Initiation Factor 2-Associated Kinase 2) is a kinase that phosphorylates and inhibits the translation initiation factor eIF2α, leading to suppression of global protein synthesis. STAT3 is a transcription factor that is activated downstream of EIF2AK2 and plays a role in regulating autophagy. Inhibition of autophagy by EIF2AK2 has been shown to be mediated in part by the activation of STAT3, which can suppress the expression of autophagy-related genes."
  },
  {
    "id": 973,
    "user_query": "Describe what is the usage of the Theatre software tool for genomic analysis.",
    "llama-2-7b-chat-hf_response": "Theatre is a software tool for genomic analysis that is specifically designed for the analysis of chromatin structure and epigenetic marks. It is used to visualize and analyze the spatial organization of chromatin in cells, and to identify patterns and relationships between different regions of the genome.\nHere are some of the key ways in which Theatre can be used for genomic analysis:\n1. Chromatin structure visualization: Theatre can be used to visualize the three-dimensional structure of chromatin, including the locations of nucleosomes, chromatin loops, and other structural features. This can help researchers to understand how chromatin is organized in different regions of the genome and how this organization affects gene expression.\n2. Epigenetic mark analysis: Theatre can be used to visualize and analyze the distribution of epigenetic marks, such as histone modifications and DNA methylation, across the genome. This can help researchers to identify patterns and relationships between different epigenetic marks and to understand how they contribute to the regulation of gene expression.\n3. Genomic interaction analysis: Theatre can be used to visualize and analyze the interactions between different regions of the genome, including the interactions between promoters, enhancers, and other regulatory elements. This can help researchers to understand how these interactions contribute to the regulation of gene expression and to identify potential regulatory elements.\n4. Gene regulation analysis: Theatre can be used to visualize and analyze the regulation of specific genes, including the interactions between promoters, enhancers, and other regulatory elements. This can help researchers to understand how these interactions contribute to the regulation of gene expression and to identify potential regulatory elements.\n5. High-throughput sequencing data analysis: Theatre can be used to analyze high-throughput sequencing data, such as ChIP-seq and RNA-seq data, to identify patterns and relationships between different regions of the genome and to understand how they contribute to the regulation of gene expression.\nOverall, Theatre is a powerful tool for understanding the complex interactions between chromatin structure, epigenetic marks, and gene regulation, and it has a wide range of applications in the field of genomics."
  },
  {
    "id": 997,
    "user_query": "Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences",
    "llama-2-7b-chat-hf_response": "The execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences depends on the specific implementation and the length of the sequences. However, in general, the time complexity of the Smith-Waterman algorithm is O(n^2), where n is the length of the shorter sequence.\nThe basic idea of the Smith-Waterman algorithm is to compute the similarity between two sequences by computing the similarity between their substrings. The algorithm scans the sequences one position at a time, and for each position, it computes the similarity between the two sequences based on the similarity of their substrings. The algorithm repeats this process until it reaches the end of the sequences.\nThe time complexity of this process can be broken down as follows:\n1. For each position in the shorter sequence, the algorithm needs to compare it with every position in the longer sequence, which takes O(n) time.\n2. For each position in the shorter sequence, the algorithm needs to compute the similarity between the shorter sequence and the longer sequence, which takes O(n) time.\n3. Therefore, the total time complexity of the Smith-Waterman algorithm is O(n^2), where n is the length of the shorter sequence.\nIt's worth noting that this time complexity assumes that the sequences are compared one position at a time, and that the similarity between two positions is computed only once, even if the sequences are compared multiple times. In practice, the time complexity of the Smith-Waterman algorithm can be improved by using techniques such as caching the similarity values for frequently accessed positions, or using a more efficient data structure to store the similarity values."
  },
  {
    "id": 1004,
    "user_query": "Which SLC family is FLVCR1 a member of?",
    "llama-2-7b-chat-hf_response": "FLVCR1 is a member of the Solute Carrier (SLC) family of proteins. Specifically, it is a member of the SLC16A subfamily, which is also known as the vesicular transport protein family."
  },
  {
    "id": 1047,
    "user_query": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach.",
    "llama-2-7b-chat-hf_response": "GATA-1, a transcription factor crucial for regulating erythroid cell development, has been shown to interact with several proteins through various biochemical and functional assays. The biotinylation tagging approach has been used to identify several GATA-1 interacting partners. Here are some of the key partners identified:\n1. β-catenin: GATA-1 was shown to interact with β-catenin through its DNA-binding domain, suggesting a role for GATA-1 in regulating β-catenin function in erythroid cells.\n2. KAT2A: GATA-1 was found to interact with the histone acetyltransferase KAT2A, which is involved in regulating chromatin structure and gene expression.\n3. TFAP2A: GATA-1 was shown to interact with TFAP2A, a transcription factor that regulates erythroid cell development and differentiation.\n4. HMX1: GATA-1 was found to interact with HMX1, a homeobox transcription factor that plays a role in regulating erythroid cell development and differentiation.\n5. TFAP4: GATA-1 was shown to interact with TFAP4, a transcription factor that regulates the expression of genes involved in erythroid cell development and differentiation.\n6. RFX1: GATA-1 was found to interact with RFX1, a transcription factor that regulates the expression of genes involved in erythroid cell development and differentiation.\n7. NF-E2: GATA-1 was shown to interact with NF-E2, a transcription factor that regulates the expression of genes involved in erythroid cell development and differentiation.\n8. CBX3: GATA-1 was found to interact with CBX3, a chromodomain-containing protein that regulates the expression of genes involved in erythroid cell development and differentiation.\n9. HMGA2: GATA-1 was shown to interact with HMGA2, a non-histone chromosomal protein that regulates the expression of genes involved in erythroid cell development and differentiation.\n10. SUV39H1: GATA-1 was found to interact"
  },
  {
    "id": 1072,
    "user_query": "What is the outcome of TAF10 interacting with the GATA1 transcription factor?",
    "llama-2-7b-chat-hf_response": "TAF10 (TATA-binding protein-associated factor 10) interacts with the GATA1 (GATA-binding protein 1) transcription factor to regulate the activation of gene expression, particularly in the context of erythroid cell differentiation. The interaction between TAF10 and GATA1 leads to the recruitment of RNA polymerase II and the initiation of transcription of genes involved in erythropoiesis. In summary, the outcome of TAF10 interacting with GATA1 is the activation of erythroid gene expression."
  },
  {
    "id": 1082,
    "user_query": "Are there any Decision support systems for chronic pain management ?",
    "llama-2-7b-chat-hf_response": "Yes, there are several decision support systems (DSS) available for chronic pain management. These systems are designed to help healthcare providers make informed decisions about the management of chronic pain, taking into account individual patient factors, such as medical history, lifestyle, and preferences. Some examples of DSS for chronic pain management include:\n1. Chronic Pain Management System (CPMS): This DSS is designed to help primary care physicians manage chronic pain in their patients. It provides a structured approach to assessing and managing chronic pain, including a pain severity scale, a medication management module, and a patient education module.\n2. PainAssessment.com: This DSS is an online tool that helps healthcare providers assess and manage chronic pain in their patients. It includes a pain assessment tool, a treatment planning module, and a patient education module.\n3. PainCare: This DSS is designed to help healthcare providers manage chronic pain in their patients. It includes a pain assessment tool, a treatment planning module, and a patient education module.\n4. Pain-Qol: This DSS is designed to assess and manage chronic pain in patients. It includes a pain severity scale, a quality of life assessment tool, and a treatment planning module.\n5. Chronic Pain Management Toolkit: This DSS is designed to help healthcare providers manage chronic pain in their patients. It includes a pain assessment tool, a treatment planning module, and a patient education module.\n6. Pain Management Collaborative (PMC): This DSS is designed to help healthcare providers manage chronic pain in their patients. It includes a pain assessment tool, a treatment planning module, and a patient education module.\n7. Chronic Pain Management System (CPMS): This DSS is designed to help primary care physicians manage chronic pain in their patients. It provides a structured approach to assessing and managing chronic pain, including a pain severity scale, a medication management module, and a patient education module.\n8. Pain Care Network (PCN): This DSS is designed to help healthcare providers manage chronic pain in their patients. It includes a pain assessment tool, a treatment planning module, and a patient education module.\n9. Chronic Pain Management (CP"
  },
  {
    "id": 1149,
    "user_query": "Which is the subcellular localization of the protein angiogenin?",
    "llama-2-7b-chat-hf_response": "Angiogenin is a secreted protein that localizes to the extracellular space and the Golgi apparatus. It can also be found in the cytoplasm and nucleus of cells, particularly in endothelial cells and immune cells, where it plays a role in angiogenesis and inflammation."
  },
  {
    "id": 1161,
    "user_query": "How does ranolazine affect kinase signaling activation in the heart?",
    "llama-2-7b-chat-hf_response": "Ranolazine, a cardiovascular drug, inhibits the activation of kinase signaling pathways in the heart, specifically the Akt/PKB pathway, which is involved in cell survival and contractility. By inhibiting the activation of this pathway, ranolazine reduces the ability of the heart to respond to stress and promotes cardiac protection."
  },
  {
    "id": 1225,
    "user_query": "Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?",
    "llama-2-7b-chat-hf_response": "No, the regulation of Vsr endonuclease is not entirely independent of the growth phase of bacteria. While Vsr is constitutively expressed in many bacterial species, its activity can be regulated in response to changes in the growth phase. For example, in E. coli, Vsr activity is highest during the exponential growth phase and decreases during the stationary phase. This is thought to be due to the degradation of the Vsr protein by the proteasome during the stationary phase. Additionally, the expression of the genes encoding Vsr's regulatory proteins, such as the VsrR regulatory protein, can also be regulated in response to changes in the growth phase."
  },
  {
    "id": 1233,
    "user_query": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?",
    "llama-2-7b-chat-hf_response": "There are several computational tools available for the prediction of beta-barrel transmembrane proteins. Some of the commonly used tools include:\n1. TMHMM: This is a widely used tool for predicting the transmembrane helices in a protein. It uses a combination of sequence analysis and structural information to predict the transmembrane topology of a protein.\n2. Topo-TOPO: This tool uses a combination of sequence analysis and structural information to predict the transmembrane topology of a protein. It also predicts the orientation of the transmembrane helices and the presence of glycosylation sites.\n3. Predict-TMD: This tool uses a combination of sequence analysis and structural information to predict the transmembrane topology of a protein. It also predicts the orientation of the transmembrane helices and the presence of glycosylation sites.\n4. Bioinformatics tools such as SignalP, TMHMM, and Predict-TMD can be used to predict the presence of signal peptides in a protein.\n5. PHD-TOPO: This tool predicts the transmembrane topology of a protein based on the presence of hydrophobic regions in the protein sequence.\n6. SOSUI: This tool predicts the transmembrane topology of a protein based on the presence of hydrophobic regions in the protein sequence and the secondary structure of the protein.\n7. TOPOTOP: This tool predicts the transmembrane topology of a protein based on the presence of hydrophobic regions in the protein sequence and the secondary structure of the protein.\n8. Protter: This tool predicts the transmembrane topology of a protein based on the presence of hydrophobic regions in the protein sequence and the secondary structure of the protein.\n9. TM-align: This tool predicts the transmembrane topology of a protein based on the presence of hydrophobic regions in the protein sequence and the secondary structure of the protein.\n10. TM-PSSM: This tool predicts the transmembrane topology of a protein based on the presence of hydrophobic regions in the protein sequence and the secondary structure of the protein.\nIt's important to note that these tools are not perfect and may not always predict the correct topology of a protein, so it's always a good idea"
  },
  {
    "id": 1251,
    "user_query": "Galassi classification is used for which disorder?",
    "llama-2-7b-chat-hf_response": "Galassi classification is used to classify disorders related to the function of the cerebral cortex, specifically those involving the frontal and parietal lobes. The classification system was developed by Dr. Francesco Galassi and colleagues."
  },
  {
    "id": 1304,
    "user_query": "List common features of Shapiro syndrome",
    "llama-2-7b-chat-hf_response": "Shapiro syndrome, also known as Shapiro-Heller syndrome, is a rare genetic disorder characterized by a range of symptoms affecting the eyes, nervous system, and other body systems. Here are some common features of Shapiro syndrome:\n1. Retinal abnormalities: The most common feature of Shapiro syndrome is a range of retinal abnormalities, including microphthalmia (small eyes), anophthalmia (absence of one or both eyes), coloboma (a hole in the iris), and cataracts.\n2. Neurological problems: People with Shapiro syndrome may experience a range of neurological problems, including seizures, developmental delays, intellectual disability, and problems with coordination and balance.\n3. Skeletal abnormalities: Shapiro syndrome can cause various skeletal abnormalities, such as short stature, scoliosis (curvature of the spine), and other bone deformities.\n4. Cardiovascular problems: Some individuals with Shapiro syndrome may experience cardiovascular problems, including heart defects and abnormalities in the structure and function of the aorta.\n5. Genital abnormalities: Males with Shapiro syndrome may have undescended testes (cryptorchidism), while females may have irregular menstrual cycles or infertility.\n6. Ear abnormalities: Shapiro syndrome can cause various ear abnormalities, including small or malformed ears, and hearing loss.\n7. Dental abnormalities: People with Shapiro syndrome may have abnormalities in the development of their teeth, including small or missing teeth, and abnormal tooth alignment.\n8. Gastrointestinal problems: Some individuals with Shapiro syndrome may experience gastrointestinal problems, including constipation, diarrhea, and other digestive issues.\n9. Kidney problems: Shapiro syndrome can cause kidney problems, including kidney failure and other renal abnormalities.\n10. Other symptoms: Other symptoms of Shapiro syndrome can include growth delays, delayed speech and language development, and an increased risk of infections.\nIt's important"
  },
  {
    "id": 1320,
    "user_query": "Which disease is linked to mutations within BRAG1?",
    "llama-2-7b-chat-hf_response": "BRAG1 (BRAG1-related gene 1) is linked to a rare genetic disorder called BRAG1-related syndrome, which is characterized by a range of symptoms including developmental delays, intellectual disability, seizures, and distinctive facial features. Mutations in the BRAG1 gene can cause this syndrome."
  },
  {
    "id": 1362,
    "user_query": "Which protein is the main inhibitor of protein phosphatase 1 (PP1)?",
    "llama-2-7b-chat-hf_response": "The main inhibitor of protein phosphatase 1 (PP1) is the protein called PP1-specific inhibitor (PPI)."
  },
  {
    "id": 1374,
    "user_query": "Which mechanisms underlie adaptive mutagenesis (stationary-phase mutagenesis) in Bacillus subtilis?",
    "llama-2-7b-chat-hf_response": "Adaptive mutagenesis, also known as stationary-phase mutagenesis, in Bacillus subtilis involves the increased mutation rate of the genome during the stationary phase of growth, which is a period of limited nutrient availability. There are several mechanisms that underlie this process:\n1. DNA damage: The stationary phase is characterized by high levels of DNA damage, including base modifications, strand breaks, and cross-links. This damage can lead to the formation of mutagenic lesions, which can increase the mutation rate.\n2. Reactive oxygen species (ROS): ROS, such as hydrogen peroxide, can damage DNA and lead to mutations. The stationary phase is a period of increased ROS production, which can contribute to the high mutation rate during this phase.\n3. Methylation of DNA damage response proteins: In the stationary phase, the levels of DNA damage response proteins, such as the SOS response proteins, are reduced. This can lead to an accumulation of unrepaired DNA damage, which can increase the mutation rate.\n4. Chromatin structure: The stationary phase can lead to changes in chromatin structure, such as compaction and decondensation, which can affect the accessibility of DNA to repair machinery and increase the mutation rate.\n5. Transcriptional regulation: The expression of genes involved in DNA repair and mutagenesis can be regulated during the stationary phase. For example, the expression of the RecA recombinase, which is involved in DNA repair, is downregulated during the stationary phase, which can increase the mutation rate.\n6. Increased error-prone repair: During the stationary phase, the cell may use error-prone repair mechanisms, such as nucleotide excision repair, which can increase the mutation rate.\n7. Increased mutation rate in specific genes: Some genes, such as those involved in DNA repair and recombination, have a higher mutation rate during the stationary phase than other genes.\n8. Epigenetic modifications: Epigenetic modifications, such as DNA methylation and histone modifications, can also play a role in adaptive mutagenesis. For example, DNA methylation can repress the expression of genes involved in"
  },
  {
    "id": 1399,
    "user_query": "What causes erucism?",
    "llama-2-7b-chat-hf_response": "Erucism, also known as erucismatosis or erucistic dermatitis, is a rare inflammatory skin condition that is caused by an allergic reaction to the compound erucic acid, which is found in the seeds of the erucula plant (Raphanus sativus var. eruca). Erucic acid is a fatty acid that is naturally occurring in the plant and is used as a food additive in some countries.\nThe exact cause of erucism is not fully understood, but it is believed to occur when the skin comes into contact with erucic acid, which triggers an allergic response. The reaction can occur through inhalation, ingestion, or direct contact with the skin.\nSymptoms of erucism typically appear within a few hours to a few days after exposure to erucic acid and can include:\n* Redness and swelling of the skin\n* Itching and burning sensations\n* Blisters or hives\n* Pus-filled bumps or nodules\n* Skin thickening and scarring\nIn severe cases, erucism can lead to more serious complications, such as:\n* Skin infections\n* Eye irritation or vision problems\n* Respiratory problems\nIf you suspect that you have erucism, it is important to seek medical attention from a healthcare professional. They can diagnose the condition based on a physical examination and medical history, and provide appropriate treatment."
  },
  {
    "id": 1413,
    "user_query": "What are the indications for hydrochlorothiazide?",
    "llama-2-7b-chat-hf_response": "Hydrochlorothiazide is a diuretic medication that is commonly used to treat a variety of medical conditions, including:\n1. Hypertension (high blood pressure): Hydrochlorothiazide is used to lower blood pressure in patients with hypertension. It works by increasing urine production, which helps to reduce the amount of fluid in the body and lower blood pressure.\n2. Heart failure: Hydrochlorothiazide can help to reduce fluid buildup in the body, which can occur in patients with heart failure.\n3. Edema (fluid retention): Hydrochlorothiazide can help to reduce fluid buildup in the body, which can occur in patients with edema.\n4. Nephrotic syndrome: Hydrochlorothiazide can help to reduce fluid buildup in the body, which can occur in patients with nephrotic syndrome.\n5. Diabetes insipidus: Hydrochlorothiazide can help to reduce fluid buildup in the body, which can occur in patients with diabetes insipidus.\n6. Kidney disease: Hydrochlorothiazide can help to reduce fluid buildup in the body, which can occur in patients with kidney disease.\n7. Liver disease: Hydrochlorothiazide can help to reduce fluid buildup in the body, which can occur in patients with liver disease.\n8. Angiotensin-converting enzyme (ACE) inhibitor-induced potassium loss: Hydrochlorothiazide can help to reduce potassium levels in the body, which can occur in patients taking ACE inhibitors.\n9. Hyperlipidemia (high cholesterol): Hydrochlorothiazide can help to reduce cholesterol levels in the blood, which can occur in patients with hyperlipidemia.\n10. Mild to moderate hypertension in children: Hydrochlorothiazide can be used to treat mild to moderate hypertension in children.\nIt is important to note that hydrochlorothiazide can have side effects, especially when taken in high doses or for a long time. Therefore, it is important to use this medic"
  },
  {
    "id": 1447,
    "user_query": "Has silicon been used in treatment of  incontinence ?",
    "llama-2-7b-chat-hf_response": "Yes, silicon has been used in the treatment of incontinence. Silicon-based materials have been developed and used in various forms to help manage and treat incontinence, including:\n1. Silicone gel-filled meshes: These are used to support the urethra and bladder neck, helping to prevent leakage of urine.\n2. Silicone-coated meshes: These are used to treat stress urinary incontinence by supporting the urethra and bladder neck.\n3. Silicone catheters: These are used to collect urine in individuals with urinary retention or incontinence.\n4. Silicone-based drugs: Some drugs, such as silicon-based antibiotics, have been developed to treat urinary tract infections.\nIt is important to note that the use of silicon in the treatment of incontinence is still a developing area of research, and more studies are needed to fully understand its effectiveness and safety. Additionally, silicon-based treatments may not be suitable for everyone and should be discussed with a healthcare provider."
  },
  {
    "id": 1454,
    "user_query": "What is the association between moon cycle and rupture risk of intracranial aneurysms?",
    "llama-2-7b-chat-hf_response": "There is a controversial association between the moon cycle and the risk of rupture of intracranial aneurysms. Some studies have suggested that the incidence of rupture of intracranial aneurysms may be higher during the full moon, possibly due to changes in blood pressure and vessel diameter. However, other studies have found no significant correlation between the moon cycle and aneurysm rupture risk. The exact mechanism underlying this association is not well understood and requires further investigation."
  },
  {
    "id": 1477,
    "user_query": "Does HuR protein regulate the splicing process?",
    "llama-2-7b-chat-hf_response": "Yes, HuR protein (also known as ELAVL1) is known to regulate the splicing process in various cell types. HuR is an RNA-binding protein that plays a critical role in the regulation of mRNA splicing, particularly in the cytoplasm. It recognizes and binds to specific sequences in the 3' untranslated region (UTR) of target mRNAs and modulates their splicing patterns by blocking or enhancing the activity of splicing factors.\nHuR has been shown to regulate the splicing of a variety of mRNAs involved in different biological processes, including cell proliferation, differentiation, and survival. For example, HuR has been shown to promote the splicing of the Bcl-2 mRNA, leading to increased expression of the anti-apoptotic protein Bcl-2 and resistance to chemotherapy in cancer cells. HuR has also been implicated in the regulation of splicing of mRNAs involved in neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.\nIn summary, HuR protein plays a critical role in regulating the splicing process in various cell types, and its dysregulation has been implicated in a variety of diseases, including cancer and neurodegenerative disorders."
  },
  {
    "id": 1492,
    "user_query": "Describe the known functions for the prothymosin alpha c-terminal peptide?",
    "llama-2-7b-chat-hf_response": "The prothymosin alpha c-terminal peptide (PCT) has been shown to have a variety of functions in the body, including:\n1. Regulation of cell proliferation and differentiation: PCT has been shown to inhibit the proliferation of certain cell types, such as tumor cells, and to promote the differentiation of stem cells.\n2. Anti-inflammatory effects: PCT has been shown to have anti-inflammatory properties, and may play a role in the regulation of immune responses.\n3. Neuroprotection: PCT has been shown to have neuroprotective effects, and may play a role in the protection of neurons against damage caused by various insults, such as oxidative stress and excitotoxicity.\n4. Cardiovascular protection: PCT has been shown to have cardiovascular protective effects, and may play a role in the prevention of cardiovascular disease.\n5. Anti-aging effects: PCT has been shown to have anti-aging effects, and may play a role in the promotion of healthy aging and the prevention of age-related diseases.\n6. Regulation of circadian rhythms: PCT has been shown to regulate circadian rhythms, and may play a role in the regulation of the body's internal clock.\n7. Modulation of the immune response: PCT has been shown to modulate the immune response, and may play a role in the regulation of immune function.\n8. Anti-tumor effects: PCT has been shown to have anti-tumor effects, and may play a role in the prevention and treatment of cancer.\nIt is worth noting that the functions of PCT are not limited to the above list, and it may have other functions in the body that have not yet been fully elucidated."
  },
  {
    "id": 1516,
    "user_query": "Which peptide plays a pivotal role in human cystatin C fibrillization?",
    "llama-2-7b-chat-hf_response": "The peptide that plays a pivotal role in human cystatin C fibrillization is the amino acid sequence RRARRR. This sequence is found in the N-terminal region of human cystatin C and is responsible for the formation of fibrils in vitro."
  },
  {
    "id": 1574,
    "user_query": "Does the concentration of protein HIF-1α increase after the administration of the cytoprotective prodrug\"amifostine\" (ethyol) ?",
    "llama-2-7b-chat-hf_response": "Yes, the concentration of protein HIF-1α (hypoxia-inducible factor 1 alpha) increases after the administration of the cytoprotective prodrug amifostine (ethyol). Amifostine is a phosphodiesterase inhibitor that activates the protein HIF-1α by preventing the degradation of its messenger RNA (mRNA), leading to increased protein expression and activity. HIF-1α plays a critical role in adapting cellular metabolism and response to hypoxia, and its activation by amifostine can help protect cells against oxidative stress and other harmful effects of radiation and chemotherapy."
  },
  {
    "id": 1588,
    "user_query": "Which histone marks are deposited by Set7?",
    "llama-2-7b-chat-hf_response": "Set7 is a histone methyltransferase that deposits histone H3 lysine 4 trimethylation (H3K4me3) marks on histone proteins in various cell types, including stem cells, progenitor cells, and cancer cells. H3K4me3 is a repressive mark that can silence gene expression by blocking the activation of transcription factors and recruiting histone-modifying enzymes that remove activating marks."
  },
  {
    "id": 1620,
    "user_query": "How many disulfide bridges has the protein hepcidin got?",
    "llama-2-7b-chat-hf_response": "Hepcidin has 4 disulfide bridges."
  },
  {
    "id": 1643,
    "user_query": "What is the localization of the protein encoded by the gene DNAJC11?",
    "llama-2-7b-chat-hf_response": "DNAJC11 encodes a protein that is predominantly localized to the mitochondria."
  },
  {
    "id": 1655,
    "user_query": "Are ultraconserved elements depleted among copy number variants (CNVs)?",
    "llama-2-7b-chat-hf_response": "Yes, ultraconserved elements (UEs) are depleted among copy number variants (CNVs). UEs are short, conserved sequences that are found throughout the genome, and they are typically associated with regulatory elements such as promoters and enhancers. CNVs, on the other hand, are genetic variations that involve the gain or loss of DNA sequences, and they can affect the expression of genes and the regulation of gene expression.\nStudies have shown that UEs are enriched in regions of the genome that are not affected by CNVs, and that CNVs are often associated with the loss of UEs. This suggests that UEs are particularly important for the regulation of gene expression and that their loss can have important consequences for the proper functioning of the genome.\nOne study published in the journal Nature in 2015 found that UEs are depleted among CNVs in a variety of organisms, including humans. The study used a combination of computational and experimental approaches to identify UEs and CNVs in the human genome, and found that only a small proportion of UEs were found within CNVs.\nAnother study published in the journal Science in 2017 found that the depletion of UEs among CNVs is a general feature of mammalian genomes. The study used a combination of sequencing and computational approaches to identify UEs and CNVs in a variety of mammalian species, and found that UEs were significantly less frequent in CNVs than in non-CNV regions of the genome.\nOverall, these studies suggest that UEs are an important component of the genome that are particularly vulnerable to disruption by CNVs, and that the loss of UEs may have important consequences for the proper functioning of the genome."
  },
  {
    "id": 1665,
    "user_query": "Which is the substrate of the haspin kinase during mitosis?",
    "llama-2-7b-chat-hf_response": "Hasatin kinase, also known as Haspin, is a protein that plays a crucial role in regulating the progression of mitosis. The substrate of Haspin during mitosis is the histone H3. Haspin phosphorylates histone H3 on specific residues, leading to the stabilization of the chromatin structure and the proper progression of mitosis."
  },
  {
    "id": 1696,
    "user_query": "What is the mechanism of viroid replication?",
    "llama-2-7b-chat-hf_response": "Viroid replication is a unique mechanism of replication that involves the RNA molecule itself, rather than a cellular machinery. Here's how it works:\nViroids are small, single-stranded RNA molecules that replicate by a process called \"self-replication.\" They are not dependent on a host cell's machinery for replication, but instead, they use their own RNA sequence to produce new copies of themselves.\nThe replication process of viroids involves the following steps:\n1. Binding: The viroid RNA binds to a specific host cell receptor, usually a transmembrane protein.\n2. Unwinding: The viroid RNA unwinds and separates into two complementary single-stranded RNA molecules.\n3. Synthesis: The two complementary RNA molecules serve as templates for the synthesis of new viroid RNA molecules by the host cell's RNA polymerase enzyme.\n4. Encapsidation: The new RNA molecules are then encapsidated (wrapped) in a protein coat, which protects them from degradation and helps them to move within the cell.\n5. Maturation: The encapsidated RNA molecules mature and become infectious, ready to be released from the host cell and infect other cells.\nIn summary, the mechanism of viroid replication involves the use of the RNA molecule itself as a template for the synthesis of new RNA molecules, which are then encapsidated and matured to become infectious. This unique mechanism of replication is what makes viroids different from other viruses that rely on a host cell's machinery for replication."
  },
  {
    "id": 1723,
    "user_query": "Does fibronectin constitute a serum biomarker for Duchenne muscular dystrophy?",
    "llama-2-7b-chat-hf_response": "Yes, fibronectin has been identified as a potential serum biomarker for Duchenne muscular dystrophy (DMD). Studies have shown that levels of fibronectin in the bloodstream are significantly increased in individuals with DMD, particularly during the early stages of the disease. This increase in fibronectin is thought to be due to the excessive production of fibronectin in muscle tissue in response to the disease-causing mutations in the dystrophin gene.\nThe use of fibronectin as a biomarker for DMD has several advantages, including its simplicity and non-invasive nature, as well as its potential to detect the disease at an early stage. However, further research is needed to validate the use of fibronectin as a biomarker for DMD and to determine its clinical utility."
  },
  {
    "id": 1763,
    "user_query": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?",
    "llama-2-7b-chat-hf_response": "The DeepBlue epigenomic data server contains data from several major epigenome projects, including:\n1. The ENCODE (ENCyclopedia Of DNA Elements) project, which aims to map all the functional elements in the human genome.\n2. The Roadmap Epigenomics Project, which aims to create a comprehensive map of the epigenetic marks in various organisms, including humans.\n3. The Epigenetics Roadmap Project, which aims to create a comprehensive map of the epigenetic marks in various organisms, including humans.\n4. The Human Epigenome Project, which aims to create a comprehensive map of the epigenetic marks in human cells and tissues.\n5. The Mouse Epigenome Project, which aims to create a comprehensive map of the epigenetic marks in mouse cells and tissues.\n6. The Epigenetic Atlas of Human Disease, which aims to identify epigenetic changes associated with various diseases, including cancer and neurological disorders.\n7. The Epigenetic Regulation of Stem Cells, which aims to understand the epigenetic mechanisms that regulate stem cell function and differentiation.\n8. The Epigenetic Control of Gene Expression, which aims to understand the epigenetic mechanisms that control gene expression and their role in various diseases.\n9. The Epigenetic Modifications in Cancer, which aims to understand the epigenetic changes that occur in cancer and their role in tumor progression and treatment resistance.\n10. The Epigenetic Modifications in Neurological Disorders, which aims to understand the epigenetic changes that occur in neurological disorders, such as Alzheimer's disease and Parkinson's disease.\nThese projects have generated a large amount of epigenomic data, including data on DNA methylation, histone modifications, and other epigenetic marks, which are available for analysis through the DeepBlue data server."
  },
  {
    "id": 1792,
    "user_query": "Which tool employs self organizing maps for analyzing synonymous codon usage?",
    "llama-2-7b-chat-hf_response": "The tool that employs self-organizing maps (SOM) for analyzing synonymous codon usage is called \"CodonMapper\"."
  },
  {
    "id": 1793,
    "user_query": "What is MINDY-1?",
    "llama-2-7b-chat-hf_response": "MINDY-1 (Microtubule-Associated Protein Light Chain 1) is a protein that plays a critical role in the regulation of microtubule dynamics and stability in cells. It is a key component of the plus-end tracking protein complex, which helps to regulate the growth and stability of microtubules by interacting with their plus-ends. MINDY-1 is also involved in the regulation of cell division and the maintenance of genome stability."
  },
  {
    "id": 1810,
    "user_query": "Which software package is available for the analysis of conserved genomic loci?",
    "llama-2-7b-chat-hf_response": "There are several software packages available for the analysis of conserved genomic loci, including:\n1. PhyloBLAST: This software uses a BLAST-like algorithm to identify conserved regions in multiple genomes.\n2. ConServ: This tool uses a HMM-based approach to identify conserved regions in genomic sequences.\n3. PALI (Position-Specific Scoring Matrix for Inferring Conserved Regions): This software uses a PSSM-based approach to identify conserved regions in genomic sequences.\n4. MUSCLE (Multiple Sequence Comparison by Log-Expectation): This software uses a multiple sequence alignment approach to identify conserved regions in genomic sequences.\n5. MAFFT (Multiple Alignment using Fast Fourier Transform): This software uses a multiple sequence alignment approach to identify conserved regions in genomic sequences.\n6. BLASTZ: This software uses a BLAST-like algorithm to identify conserved regions in genomic sequences.\n7. GLIMMER: This software uses a profile-based approach to identify conserved regions in genomic sequences.\n8. HMMER: This software uses a HMM-based approach to identify conserved regions in genomic sequences.\n9. Prodigal: This software uses a multiple sequence alignment approach to identify conserved regions in genomic sequences.\n10. RepeatMasker: This software uses a repeat-masking approach to identify conserved regions in genomic sequences.\nThese software packages can be used to identify conserved regions in genomic sequences, which can be useful for a variety of downstream analyses, such as functional annotation, gene prediction, and evolutionary analysis."
  },
  {
    "id": 1860,
    "user_query": "Please list 3 diseases associated with the PIEZO2 gene.",
    "llama-2-7b-chat-hf_response": "The PIEZO2 gene has been associated with several diseases, including:\n1. Hypertension: Mutations in the PIEZO2 gene have been found to be associated with essential hypertension, a common cardiovascular disease.\n2. Nephrocalcinosis: PIEZO2 mutations can lead to the accumulation of calcium in the kidneys, which can cause nephrocalcinosis, a condition characterized by the presence of calcium deposits in the kidneys.\n3. Chronic kidney disease: PIEZO2 mutations have also been linked to chronic kidney disease, a condition in which the kidneys gradually lose their function over time."
  },
  {
    "id": 1867,
    "user_query": "What is promoted by ERAP1-ERAP2 dimerization?",
    "llama-2-7b-chat-hf_response": "ERAP1-ERAP2 dimerization promotes the degradation of extracellular matrix (ECM) components, such as collagen and fibronectin, through the activation of proteases. This process is important for tissue remodeling and repair during development and in response to injury or disease."
  },
  {
    "id": 1890,
    "user_query": "What is the function of R-spondin 1 and noggin in non-damaged gallbladders?",
    "llama-2-7b-chat-hf_response": "R-spondin 1 and Noggin are two proteins that play important roles in the regulation of embryonic development and tissue homeostasis. In non-damaged gallbladders, R-spondin 1 and Noggin have been shown to play the following functions:\nR-spondin 1:\n* Regulation of gallbladder morphogenesis: R-spondin 1 is expressed in the gallbladder during embryonic development and plays a crucial role in the formation and morphogenesis of the gallbladder.\n* Maintenance of gallbladder function: R-spondin 1 is also expressed in adult gallbladders and is involved in the regulation of gallbladder function, including the secretion of bile and the contraction of the gallbladder muscle.\nNoggin:\n* Regulation of cell proliferation and differentiation: Noggin is expressed in the gallbladder and regulates the proliferation and differentiation of gallbladder epithelial cells.\n* Maintenance of gallbladder tissue homeostasis: Noggin also plays a role in maintaining the tissue homeostasis of the gallbladder by regulating the expression of genes involved in cell adhesion and migration.\nOverall, R-spondin 1 and Noggin play important roles in the development and maintenance of non-damaged gallbladders, and their dysregulation can lead to gallbladder diseases such as gallstones and cancer."
  },
  {
    "id": 1937,
    "user_query": "Does NADPH oxidase 5 require any subunit for function?",
    "llama-2-7b-chat-hf_response": "Yes, NADPH oxidase 5 (NOX5) requires several subunits to function. The core subunits of NOX5 include:\n1. NOX5P: The catalytic subunit of NOX5 that generates ROS (reactive oxygen species) through the transfer of electrons from NADPH to oxygen.\n2. p47phox: An adaptor subunit that interacts with the plasma membrane and recruits the NOX5P subunit to the membrane.\n3. p67phox: An adaptor subunit that interacts with the p47phox subunit and plays a role in the assembly of the NOX5 complex.\n4. Rac1: A small GTPase that interacts with the NOX5 complex and regulates its activity.\n5. Nox5-interacting protein 1 (NIP1): A protein that interacts with the NOX5 complex and regulates its activity.\nTogether, these subunits work cooperatively to generate ROS, which are involved in various cellular processes such as cell signaling, migration, and proliferation."
  },
  {
    "id": 1944,
    "user_query": "What is the connection between furin and hepcidin?",
    "llama-2-7b-chat-hf_response": "Furin and hepcidin are connected in the regulation of iron metabolism. Furin is a protease that cleaves the precursor protein hepcidin to produce the active form of hepcidin, which in turn inhibits iron absorption in the duodenum and promotes iron efflux from macrophages, thereby regulating iron homeostasis in the body."
  },
  {
    "id": 1956,
    "user_query": "Which is the largest metabolic gene cluster in yeast?",
    "llama-2-7b-chat-hf_response": "The largest metabolic gene cluster in yeast is the glycolytic pathway, also known as the Embden-Meyerhof pathway. This pathway is responsible for the breakdown of glucose and produces pyruvate, which can be used to produce ATP through the electron transport chain. The glycolytic pathway is composed of 10 genes and is the most well-studied metabolic pathway in yeast."
  },
  {
    "id": 1967,
    "user_query": "What is the role of LIMT lncRNA?",
    "llama-2-7b-chat-hf_response": "LIMT (Long Non-Coding RNA in Myeloid cells Inhibits Transcription) is a long non-coding RNA (lncRNA) that has been shown to play a negative regulatory role in the expression of genes involved in myeloid cell differentiation and function. Specifically, LIMT has been shown to inhibit the expression of genes involved in the myeloid cell lineage, including genes involved in the differentiation of myeloid cells into macrophages and granulocytes.\nLIMT is known to function by binding to the promoter regions of these genes and preventing the recruitment of RNA polymerase, the enzyme responsible for transcribing DNA into RNA, to these regions. This leads to a decrease in the expression of these genes and a resulting decrease in the differentiation of myeloid cells.\nAdditionally, LIMT has been shown to play a role in the regulation of cellular processes such as cell adhesion, migration, and survival. It has also been implicated in the development and progression of certain diseases, including cancer and autoimmune disorders.\nOverall, the role of LIMT lncRNA is to negatively regulate the expression of genes involved in myeloid cell differentiation and function, and it is a promising area of research for understanding the regulation of myeloid cell biology and the development of new therapeutic strategies for diseases such as cancer and autoimmune disorders."
  },
  {
    "id": 1984,
    "user_query": "Which R / bioconductor package is used for performing SNP enrichment analysis?",
    "llama-2-7b-chat-hf_response": "There are several R packages and bioconductor packages that can be used for performing SNP (Single Nucleotide Polymorphism) enrichment analysis. Some of the commonly used packages are:\n1. 'SNPset' package: This package provides a comprehensive set of tools for performing SNP enrichment analysis. It can be used to identify overrepresented SNPs in a set of genes or regions of interest.\n2. 'Enrichr' package: This package uses a Bayesian approach to identify overrepresented SNPs in a given dataset. It can be used to identify SNPs that are enriched in functional regions of the genome, such as gene regulatory elements.\n3. 'GSEA' package: This package uses a modified version of the Gene Set Enrichment Analysis (GSEA) method to identify overrepresented gene sets in a given dataset. It can be used to identify SNPs that are enriched in specific gene sets or pathways.\n4. 'Pathway studio' package: This package provides a comprehensive set of tools for pathway analysis. It can be used to identify overrepresented pathways in a given dataset, including those that are enriched with SNPs.\n5. 'Plink' package: This package provides a simple and efficient way to perform SNP analysis. It can be used to perform a variety of SNP analysis tasks, including enrichment analysis.\n6. 'MAST' package: This package provides a comprehensive set of tools for genome-wide association study (GWAS) analysis. It can be used to identify overrepresented SNPs in a given dataset, including those that are enriched in functional regions of the genome.\n7. 'GWASeq' package: This package provides a comprehensive set of tools for GWAS analysis, including enrichment analysis. It can be used to identify overrepresented SNPs in a given dataset, including those that are enriched in functional regions of the genome.\n8. 'GenomicRanges' package: This package provides a comprehensive set of tools for genomic range analysis. It can be used to identify overrepresented SNPs in a given dataset, including those that are enriched in functional regions of the genome.\n9. 'SNP"
  },
  {
    "id": 2015,
    "user_query": "Which are the key players on radial glial specification to ependymal cells?",
    "llama-2-7b-chat-hf_response": "Radial glial cells are intermediate progenitors that give rise to ependymal cells in the central nervous system (CNS). The key players involved in radial glial specification to ependymal cells include:\n1. Notch signaling pathway: Notch is a transmembrane receptor that plays a crucial role in the regulation of cell fate decisions, including the specification of radial glial cells to ependymal cells.\n2. Wnt/β-catenin signaling pathway: Wnt/β-catenin signaling is involved in the regulation of radial glial cell fate decisions, including the maintenance of radial glial identity and the induction of ependymal cell fate.\n3. BMP signaling pathway: BMP (bone morphogenetic protein) signaling is involved in the regulation of radial glial cell fate decisions, including the induction of ependymal cell fate.\n4. Shh signaling pathway: Shh (sonic hedgehog) signaling is involved in the regulation of radial glial cell fate decisions, including the induction of ependymal cell fate.\n5. FGF signaling pathway: Fibroblast growth factor (FGF) signaling is involved in the regulation of radial glial cell fate decisions, including the induction of ependymal cell fate.\n6. EGFR signaling pathway: Epidermal growth factor receptor (EGFR) signaling is involved in the regulation of radial glial cell fate decisions, including the induction of ependymal cell fate.\n7. PI3K/Akt signaling pathway: Phosphatidylinositol 3-kinase (PI3K)/Akt signaling is involved in the regulation of radial glial cell fate decisions, including the maintenance of radial glial identity and the induction of ependymal cell fate.\n8. Hippo signaling pathway: Hippo signaling is involved in the regulation of radial glial cell fate decisions, including the maintenance of radial glial identity and the induction of ependymal cell fate.\n9. Yap/Tead signaling pathway: Yes-associated protein (Yap)/Tead signaling is involved in the regulation of radial glial cell fate decisions"
  },
  {
    "id": 2065,
    "user_query": "How are triple negative gliomas characterized?",
    "llama-2-7b-chat-hf_response": "Triple negative gliomas are characterized by the lack of expression of specific markers, including:\n1. Tumor suppressor proteins: TP53, PTEN, and CDKN2A (also known as p16).\n2. Receptors: EGFR, HER2, and HER3.\n3. Cyclin-dependent kinase inhibitors: CDKN1A (also known as p21) and CDKN2A (also known as p16).\nThe absence of these markers distinguishes triple negative gliomas from other types of gliomas, such as glioblastoma, which are typically characterized by the presence of these markers. Triple negative gliomas are aggressive and malignant, and they are often difficult to treat. They are typically found in adults, and the prognosis for patients with these tumors is generally poor."
  },
  {
    "id": 2069,
    "user_query": "What is TOPAZ1?",
    "llama-2-7b-chat-hf_response": "TOPAZ1 (Topoisomerase 1-associated protein AZ1) is a protein that plays a role in the regulation of DNA topoisomerase I activity and is involved in various cellular processes, including DNA replication, repair, and cell division. It is a component of the DNA damage response pathway and helps to maintain genome stability by regulating the activity of topoisomerase I, which is an enzyme that relaxes DNA supercoils. TOPAZ1 is also a tumor suppressor and its loss of function has been implicated in various types of cancer."
  },
  {
    "id": 2075,
    "user_query": "Which gene controls the expression of GATA-1 isoforms?",
    "llama-2-7b-chat-hf_response": "The expression of GATA-1 isoforms is controlled by the GATA-1 gene."
  },
  {
    "id": 2076,
    "user_query": "What is MIRA-seq?",
    "llama-2-7b-chat-hf_response": "MIRA-seq is a sequencing-based method used to identify and characterize the full-length RNA transcripts in a cell or tissue. It stands for \"Mature Isolate of RNA-seq\" and is a type of RNA sequencing (RNA-seq) method that is designed to capture the full-length transcripts of RNA molecules, including those that are not polyadenylated or have a shortened 3' end. MIRA-seq is particularly useful for studying the expression of long non-coding RNAs (lncRNAs) and other RNA molecules that are difficult to detect using traditional RNA-seq methods."
  },
  {
    "id": 2108,
    "user_query": "What is the indication of ARCALYST?",
    "llama-2-7b-chat-hf_response": "ARCALYST (rilonacept) is a prescription medication used to treat cryopyrin-associated periodic syndrome (CAPS) in adults and children aged 12 years and older, and to treat gout flares in adults. CAPS is a group of rare genetic disorders that cause recurring episodes of fever, pain, and inflammation, while gout is a type of arthritis that causes joint pain and swelling."
  },
  {
    "id": 2170,
    "user_query": "List the human acrocentric chromosomes that are involved in Robertsonian translocation.",
    "llama-2-7b-chat-hf_response": "The human acrocentric chromosomes involved in Robertsonian translocation are:\n1. Chromosome 13 (t(13;14)(q10;q32))\n2. Chromosome 14 (t(14;15)(q32;q21))\n3. Chromosome 21 (t(21;22)(q22;q11))\n4. Chromosome 22 (t(22;15)(q11;q32))\nNote: Robertsonian translocations are reciprocal translocations, meaning that the genetic material is exchanged between two chromosomes in a reciprocal manner. The above list shows the acrocentric chromosomes involved in these translocations."
  },
  {
    "id": 2237,
    "user_query": "Which R package could be used for the identification of pediatric brain tumors?",
    "llama-2-7b-chat-hf_response": "There are several R packages that can be used for the identification of pediatric brain tumors, including:\n1. \"brainTumor\": This package provides a set of tools for the analysis of brain tumor genomics data, including mutation and copy number analysis.\n2. \"pediatricTumor\": This package is specifically designed for the analysis of pediatric tumors, including brain tumors, and provides functions for the analysis of genomic and transcriptomic data.\n3. \"cBioPortal\": This package is a web-based tool for the analysis of cancer genomics data, including brain tumors, and provides functions for the analysis of mutation, copy number, and mRNA expression data.\n4. \"mutationTumor\": This package provides functions for the analysis of mutation data in cancer genomics data, including brain tumors.\n5. \"genomicTumor\": This package provides functions for the analysis of genomic data in cancer, including brain tumors, and includes tools for the analysis of mutation, copy number, and mRNA expression data.\n6. \"brainTumorGenome\": This package provides functions for the analysis of brain tumor genomics data, including mutation, copy number, and mRNA expression data.\n7. \"pediatricTumorGenome\": This package is specifically designed for the analysis of pediatric tumors, including brain tumors, and provides functions for the analysis of genomic and transcriptomic data.\n8. \"TumorGenome\": This package provides functions for the analysis of tumor genomics data, including brain tumors, and includes tools for the analysis of mutation, copy number, and mRNA expression data.\n9. \"CancerGenome\": This package provides functions for the analysis of cancer genomics data, including brain tumors, and includes tools for the analysis of mutation, copy number, and mRNA expression data.\n10. \"GDC_BrainTumor\": This package provides functions for the analysis of brain tumor genomics data, including mutation, copy number, and mRNA expression data, from The Cancer Genome Atlas (TCGA).\nPlease note that these packages are for research purposes only and are not intended to be used for clinical diagnosis or treatment."
  },
  {
    "id": 2246,
    "user_query": "Is NEMO a zinc finger protein?",
    "llama-2-7b-chat-hf_response": "No, NEMO (NF-κB essential modulator) is not a zinc finger protein. NEMO is a protein that plays a critical role in the regulation of NF-κB (nuclear factor kappa B), a transcription factor that regulates inflammation and immune responses. While NEMO does contain a zinc finger domain, it is not the primary structural component of the protein. Instead, NEMO is a adaptor protein that interacts with multiple signaling molecules, including IKKs (IκB kinases), IKKβ, and p105/p50, to modulate NF-κB activity."
  },
  {
    "id": 2247,
    "user_query": "Does TFIIS affect nucleosome positioning?",
    "llama-2-7b-chat-hf_response": "Yes, TFIIS (transcription factor IIS) can affect nucleosome positioning during transcription elongation. TFIIS is a transcriptional elongation factor that plays a critical role in the initiation and elongation of transcription by RNA polymerase II (RNAPII). It helps to position the RNAPII complex in the correct position on the DNA template and can also influence the positioning of nucleosomes along the DNA strand, which can in turn affect the transcriptional process."
  },
  {
    "id": 2262,
    "user_query": "Do origins of replication close to yeast centromeres fire early or late?",
    "llama-2-7b-chat-hf_response": "In yeast, origins of replication close to centromeres fire late."
  },
  {
    "id": 2268,
    "user_query": "Which are the properties of mammalian GA-sequences?",
    "llama-2-7b-chat-hf_response": "Mammalian GA-sequences (Glycine-Arginine) are a type of non-coding RNA sequences that are found in the introns of mammalian genes. Some of the properties of mammalian GA-sequences include:\n1. Long-range intron-exon structure: Mammalian GA-sequences are located in the introns of genes and can be hundreds of nucleotides long, spanning multiple exons.\n2. Adenine-rich: GA-sequences are rich in adenine nucleotides, which is unusual for non-coding RNA sequences.\n3. High stability: GA-sequences are more stable than other non-coding RNA sequences, such as circular RNAs (circRNAs), and are less prone to degradation.\n4. Regulation of splicing: GA-sequences can regulate the splicing of nearby exons, and their presence can influence the inclusion or exclusion of specific exons in the final mature RNA transcript.\n5. Regulation of gene expression: GA-sequences can also regulate gene expression by binding to transcription factors or other regulatory proteins, and altering their activity.\n6. Tissue-specific expression: GA-sequences are tissue-specific, with different sequences found in different tissues and cell types.\n7. Evolutionary conservation: GA-sequences are highly conserved across different species, indicating their importance in the regulation of gene expression.\n8. Interaction with other RNA molecules: GA-sequences can interact with other RNA molecules, such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), and play a role in the regulation of gene expression.\n9. Involvement in disease: GA-sequences have been implicated in a number of diseases, including cancer, neurological disorders, and metabolic disorders.\n10. Potential as therapeutic targets: GA-sequences are a promising target for the development of new therapies, as they play a critical role in the regulation of gene expression and are implicated in a number of diseases."
  },
  {
    "id": 2291,
    "user_query": "How many Groucho-related genes (GRG) are contained in the mouse genome?",
    "llama-2-7b-chat-hf_response": "The mouse genome contains 10 Groucho-related genes (GRGs), also known as Groucho-like genes (GLGs). These genes are:\n1. Groucho (Gro)\n2. Groucho-like 1 (Gl1)\n3. Groucho-like 2 (Gl2)\n4. Groucho-like 3 (Gl3)\n5. Groucho-like 4 (Gl4)\n6. Groucho-like 5 (Gl5)\n7. Groucho-like 6 (Gl6)\n8. Groucho-like 7 (Gl7)\n9. Groucho-like 8 (Gl8)\n10. Groucho-like 9 (Gl9)\nNote: The number of GRGs may vary slightly depending on the source and method of annotation."
  },
  {
    "id": 2304,
    "user_query": "Which RNA polymerase II subunit carries RNA cleavage activity?",
    "llama-2-7b-chat-hf_response": "RNA polymerase II (RNAPII) is composed of several subunits, including RNA polymerase core subunits (RPB1, RPB2, and RPB3) and additional subunits that are associated with the enzyme during transcription elongation. Of these subunits, the RPB1 subunit carries the RNA cleavage activity."
  },
  {
    "id": 2321,
    "user_query": "What is the genetic basis of Ohdo syndrome?",
    "llama-2-7b-chat-hf_response": "Ohdo syndrome is a rare genetic disorder caused by mutations in the PHLPP1 gene. The PHLPP1 gene provides instructions for making a protein called pleckstrin homology domain-containing protein 1 (PHLPP1), which is involved in the regulation of signaling pathways that are important for cell growth and division. Mutations in the PHLPP1 gene can lead to the development of Ohdo syndrome, which is characterized by a range of symptoms including growth retardation, intellectual disability, distinctive facial features, and an increased risk of developing certain cancers."
  },
  {
    "id": 2331,
    "user_query": "Which R/Bioconductor package has been developed for the analysis of psychiatric disease genes?",
    "llama-2-7b-chat-hf_response": "The R/Bioconductor package \"psychgene\" has been developed for the analysis of psychiatric disease genes. This package provides tools for the analysis of genetic data in the context of psychiatric disorders, including gene-level association analysis, pathway analysis, and gene-gene interaction analysis. It also includes tools for visualizing and interpreting the results of these analyses."
  },
  {
    "id": 2360,
    "user_query": "Describe swirl sign in intracerebral hemorrhage.",
    "llama-2-7b-chat-hf_response": "The \"swirl\" sign is a clinical sign that can be observed in patients with intracerebral hemorrhage (ICH). It is characterized by a spiral or swirling pattern of brain tissue that is visible on a computed tomography (CT) scan or magnetic resonance imaging (MRI) scan of the brain.\nThe swirl sign is caused by the movement of blood in the affected area of the brain, which can occur as a result of the hemorrhage. The blood can create a \"whirlpool\" or \"swirl\" pattern in the surrounding brain tissue, which can be seen on imaging studies. The swirl sign is often more prominent on CT scans than on MRI scans.\nThe swirl sign can be an important diagnostic marker for ICH, as it can help doctors identify the location and extent of the hemorrhage. It can also be used to monitor the progression of the hemorrhage over time. However, the swirl sign is not specific to ICH and can also be seen in other conditions, such as subarachnoid hemorrhage and cerebral edema.\nIn summary, the swirl sign is a clinical sign that can be observed on imaging studies in patients with intracerebral hemorrhage. It is caused by the movement of blood in the affected area of the brain and can help doctors diagnose and monitor the progression of the hemorrhage."
  },
  {
    "id": 2392,
    "user_query": "What induces Arabidopsis ROF1 expression?",
    "llama-2-7b-chat-hf_response": "Arabidopsis ROF1 (RNA polymerase II-associated factor 1) expression is induced by various environmental and developmental signals, including:\n1. Light: ROF1 is light-induced and plays a role in the regulation of light-responsive genes.\n2. Temperature: ROF1 expression is temperature-sensitive and is involved in the regulation of cold-inducible genes.\n3. Water availability: ROF1 is involved in the regulation of drought-responsive genes.\n4. Hormones: ROF1 is involved in the regulation of abscisic acid (ABA) and ethylene signaling.\n5. Defense against pathogens: ROF1 is involved in the regulation of pathogen-responsive genes, such as those involved in the defense against bacterial and fungal infections.\n6. Developmental processes: ROF1 is involved in the regulation of genes involved in various developmental processes, such as flower development and leaf morphogenesis.\n7. Nutrient availability: ROF1 is involved in the regulation of genes involved in the response to nutrient availability, such as nitrogen and phosphorus availability.\n8. Aging: ROF1 is involved in the regulation of genes involved in the aging process.\nPlease let me know if you need more information on any of these inducers."
  },
  {
    "id": 2398,
    "user_query": "What protein is the most common cause of hereditary  renal amyloidosis?",
    "llama-2-7b-chat-hf_response": "The most common cause of hereditary renal amyloidosis is the protein alpha-2-macroglobulin (A2M)."
  },
  {
    "id": 2407,
    "user_query": "Has the proteome of mice hippocampus been analysed?",
    "llama-2-7b-chat-hf_response": "Yes, the proteome of the mouse hippocampus has been extensively analyzed using various proteomic techniques such as two-dimensional gel electrophoresis (2DGE), mass spectrometry (MS), and label-free quantification. These studies have identified thousands of proteins that are present in the hippocampus and have provided insights into the molecular mechanisms underlying various hippocampal functions, including learning and memory, neurotransmission, and synaptic plasticity.\nSome of the key findings from these studies include:\n1. The hippocampus contains a large number of proteins involved in synaptic transmission and plasticity, such as N-methyl-D-aspartate (NMDA) receptors, AMPA receptors, and glutamate decarboxylase.\n2. The hippocampus also contains a variety of proteins involved in neuroprotection and neuronal survival, such as brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and the neuroprotective protein, neuronal pentraxin 1 (Nptx1).\n3. The hippocampus is rich in proteins involved in the regulation of gene expression, including transcription factors, chromatin remodeling complexes, and histone-modifying enzymes.\n4. The hippocampus contains proteins involved in the regulation of inflammation and immune response, such as interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α).\n5. The hippocampus is also rich in proteins involved in the regulation of energy metabolism, including proteins involved in glycolysis, the citric acid cycle, and oxidative phosphorylation.\nThese studies have provided a comprehensive view of the proteins present in the hippocampus and have identified many potential targets for the development of new therapeutic strategies for the treatment of hippocampal-related disorders, such as Alzheimer's disease and epilepsy."
  },
  {
    "id": 2409,
    "user_query": "Are mouse chromosomes acrocentric?",
    "llama-2-7b-chat-hf_response": "No, mouse chromosomes are not acrocentric. Acrocentric chromosomes are characterized by a large centromere and a short arm (p arm), while the mouse chromosomes have a more typical karyotype with a smaller centromere and longer arms (q and r arms)."
  },
  {
    "id": 2417,
    "user_query": "Which siRNA based drug is in clinical trials for the treatment of pancreatic cancer?",
    "llama-2-7b-chat-hf_response": "There are several siRNA-based drugs in clinical trials for the treatment of pancreatic cancer, including:\n1. ONX 0801: This is an investigational RNA interference (RNAi) therapeutic that targets and silences multiple cancer-promoting genes, including KRAS, in pancreatic cancer cells. ONX 0801 is being developed by Onxolate Therapeutics and is currently in Phase 2 clinical trials for the treatment of pancreatic cancer.\n2. RX-0201: This is an investigational RNAi therapeutic that targets and silences the KRAS gene in pancreatic cancer cells. RX-0201 is being developed by Rexahn Pharmaceuticals and is currently in Phase 2 clinical trials for the treatment of pancreatic cancer.\n3. AP-102: This is an investigational RNAi therapeutic that targets and silences the PD-L1 gene in pancreatic cancer cells. AP-102 is being developed by Apogenix and is currently in Phase 2 clinical trials for the treatment of pancreatic cancer.\nIt's important to note that these drugs are still in the experimental stage, and more research is needed to determine their safety and effectiveness in humans."
  },
  {
    "id": 2419,
    "user_query": "What is the HPG pore?",
    "llama-2-7b-chat-hf_response": "The HPG (Hexamethylene Glycine) pore is a type of ion channel that is found in the nuclear envelope of eukaryotic cells. It is composed of a hexamethylene glycine (HMG) sequence of amino acids and forms a porous structure that spans the nuclear envelope, allowing the passage of certain ions and small molecules. The HPG pore plays a critical role in regulating the transport of molecules between the nucleus and cytoplasm, and is involved in various cellular processes such as gene expression, cell signaling, and cell division."
  },
  {
    "id": 2472,
    "user_query": "What is the 959 Nematode Genomes initiative?",
    "llama-2-7b-chat-hf_response": "The 959 Nematode Genomes initiative is a research project aimed at sequencing and analyzing the genomes of 959 species of nematode worms, which are a group of microscopic worms that are found in a wide range of environments, including soil, plants, and animals. The initiative is led by the University of California, Berkeley and involves a collaboration of researchers from around the world.\nThe goal of the 959 Nematode Genomes initiative is to generate a comprehensive understanding of the evolution, diversity, and biology of nematodes, which are important model organisms in biology and medicine. By sequencing the genomes of such a large number of nematode species, researchers hope to identify new genes and genetic pathways that are involved in a wide range of biological processes, including development, reproduction, and disease resistance.\nThe initiative is also focused on developing new computational tools and methods for analyzing large-scale genomic data, which will be useful for analyzing the genomes of other organisms as well.\nOverall, the 959 Nematode Genomes initiative is a major undertaking that will provide new insights into the biology of nematodes and will have important implications for fields such as agriculture, medicine, and evolutionary biology."
  },
  {
    "id": 2557,
    "user_query": "Which R package has been developed for analyzing Non-invasive prenatal testing (NIPT) data?",
    "llama-2-7b-chat-hf_response": "There are several R packages that have been developed for analyzing Non-invasive prenatal testing (NIPT) data, including:\n1. NIPTkit: This package provides a comprehensive set of tools for the analysis of NIPT data, including quality control, sample classification, and variant calling.\n2. PrenatalTest: This package is specifically designed for the analysis of NIPT data and provides functions for data cleaning, filtering, and visualization.\n3. Prenatals: This package provides a set of functions for the analysis of NIPT data, including sample classification, variant calling, and risk assessment.\n4. NIPT-Analysis: This package provides a comprehensive set of tools for the analysis of NIPT data, including quality control, sample classification, and variant calling.\n5. PrenatalGenetics: This package provides a set of functions for the analysis of NIPT data, including sample classification, variant calling, and risk assessment.\n6. NIPT-Tools: This package provides a set of functions for the analysis of NIPT data, including quality control, sample classification, and variant calling.\n7. PrenatalTesting: This package provides a set of functions for the analysis of NIPT data, including sample classification, variant calling, and risk assessment.\n8. NIPT-Workflow: This package provides a set of functions for the analysis of NIPT data, including quality control, sample classification, and variant calling.\n9. Prenatals-pipeline: This package provides a set of functions for the analysis of NIPT data, including sample classification, variant calling, and risk assessment.\n10. NIPT-Analysis-pipeline: This package provides a set of functions for the analysis of NIPT data, including quality control, sample classification, and variant calling.\nPlease note that the availability and functionality of these packages may change over time, and it is recommended to consult the documentation and the authors of the packages for the most up-to-date information."
  },
  {
    "id": 2560,
    "user_query": "Describe Achenbach’s syndrome.",
    "llama-2-7b-chat-hf_response": "Achenbach's syndrome is a rare genetic disorder characterized by a variety of symptoms affecting the brain and nervous system. It is caused by mutations in the ACHENBACH gene, which is located on chromosome 16. The symptoms of Achenbach's syndrome can vary in severity and may include:\n1. Intellectual disability: Individuals with Achenbach's syndrome often have mild to moderate intellectual disability, which can range from mild cognitive impairment to more severe cognitive deficits.\n2. Autism spectrum disorder: Many individuals with Achenbach's syndrome have symptoms of autism spectrum disorder (ASD), such as difficulty with social interactions, communication, and repetitive behaviors.\n3. Seizures: Achenbach's syndrome can cause seizures, which can range from mild to severe and may be a sign of the disorder.\n4. Cerebellar ataxia: The cerebellum is a part of the brain that plays a role in coordination, balance, and movement. Individuals with Achenbach's syndrome may experience cerebellar ataxia, which can cause problems with coordination, balance, and movement.\n5. Spasticity: Spasticity is a condition characterized by stiffness and rigidity of the muscles, which can make movement difficult. Individuals with Achenbach's syndrome may experience spasticity, particularly in the legs and lower back.\n6. Scoliosis: Achenbach's syndrome can cause scoliosis, which is a curvature of the spine.\n7. Vision problems: Some individuals with Achenbach's syndrome may experience vision problems, such as blurred vision, double vision, or difficulty with depth perception.\n8. Hearing loss: Hearing loss is a common feature of Achenbach's syndrome, and can range from mild to severe.\n9. Sleep disturbances: Individuals with Achenbach's syndrome may experience sleep disturbances, such as insomnia or difficulty falling asleep.\n10. Other features: Achenbach's syndrome can also cause a range of other symptoms, including delayed"
  },
  {
    "id": 2581,
    "user_query": "Which algorithm is used for detection of long repeat expansions?",
    "llama-2-7b-chat-hf_response": "There are several algorithms used for the detection of long repeat expansions in genomic DNA, including:\n1. RepeatMasker: This algorithm uses a combination of sequence similarity and k-mer frequency to identify repetitive elements in a genome.\n2. GCG-PSI-BLAST: This algorithm uses a modified version of the BLAST algorithm to identify repetitive elements in a genome by comparing the query sequence to a database of known repetitive elements.\n3. LTR-REPEAT: This algorithm uses a combination of sequence similarity and k-mer frequency to identify long repeat elements in a genome.\n4. GATK-REPEAT: This algorithm uses a combination of sequence similarity and k-mer frequency to identify repetitive elements in a genome, and also includes a Bayesian framework for estimating the probability of each repeat being a true positive.\n5. REPEAT-FINDER: This algorithm uses a combination of sequence similarity and k-mer frequency to identify repetitive elements in a genome, and also includes a feature for identifying the type of repeat (e.g. L1, Alu, etc.).\n6. Sscrooge: This algorithm uses a combination of sequence similarity and k-mer frequency to identify repetitive elements in a genome, and also includes a feature for identifying the type of repeat (e.g. L1, Alu, etc.).\n7. RNA-seq based methods: Some methods use RNA-seq data to identify long repeat expansions by comparing the expression levels of genes in different samples.\n8. DeepSEA: This algorithm uses a combination of sequence similarity and k-mer frequency to identify repetitive elements in a genome, and also includes a feature for identifying the type of repeat (e.g. L1, Alu, etc.).\nPlease note that these are some of the commonly used algorithms, and there are many other methods available for detecting long repeat expansions. The choice of algorithm will depend on the specific research question, the type of data available, and the computational resources required."
  },
  {
    "id": 2582,
    "user_query": "Which brain tumors does neuroligin-3 promote?",
    "llama-2-7b-chat-hf_response": "Neuroligin-3 has been shown to promote the growth and progression of certain types of brain tumors, including:\n* Medulloblastoma: A type of pediatric brain cancer that originates in the cerebellum.\n* Glioblastoma: The most common and aggressive type of adult brain cancer.\n* Astrocytoma: A type of brain cancer that originates in the star-shaped glial cells called astrocytes.\n* Oligodendroglioma: A type of brain cancer that originates in the oligodendrocytes, which are the cells that produce the fatty insulating substance called myelin in the brain."
  },
  {
    "id": 2586,
    "user_query": "What is the approximate size of gas vesicles?",
    "llama-2-7b-chat-hf_response": "Gas vesicles in bacteria can vary in size, but they are typically around 10-100 nanometers (nm) in diameter. However, some gas vesicles can be larger, reaching sizes of up to 1-2 micrometers (μm) in some species."
  },
  {
    "id": 2589,
    "user_query": "List BET proteins.",
    "llama-2-7b-chat-hf_response": "BET (Bromodomain and Extra-Terminal) proteins are a family of proteins that play a crucial role in regulating gene expression by modifying chromatin structure. Here are some of the known BET proteins:\n1. BRD2 (Bromodomain-Containing Protein 2)\n2. BRD3 (Bromodomain-Containing Protein 3)\n3. BRDT (Bromodomain-Containing Protein T)\n4. BET1 (Bromodomain-Containing Protein 1)\n5. BETA (Bromodomain-Containing Protein Alpha)\n6. BRGA (Bromodomain-Containing Protein Gamma)\n7. BRGGA (Bromodomain-Containing Protein Gamma-Like)\n8. BRGKL (Bromodomain-Containing Protein Kinase-Like)\n9. BRGK (Bromodomain-Containing Protein Kinase)\n10. BETL (Bromodomain-Containing Protein Like)\nIt's worth noting that this list is not exhaustive and there may be additional BET proteins that have been identified in recent research."
  },
  {
    "id": 2610,
    "user_query": "Which algorithm has been developed for prediction of protein subcellular localization using deep learning?",
    "llama-2-7b-chat-hf_response": "One algorithm that has been developed for prediction of protein subcellular localization using deep learning is the \"DeepLoc\" algorithm. It was proposed by the group of Dr. Arshad Desai at the University of California, San Diego, and was first published in 2018.\nDeepLoc uses a deep learning model to predict the subcellular localization of a protein based on its amino acid sequence. The model is trained on a large dataset of known protein localizations, and it learns to predict the localization of a new protein by analyzing its sequence features. The algorithm has been shown to be highly accurate and outperforms traditional machine learning methods in predicting protein localization.\nThe basic idea of DeepLoc is to use a deep neural network to learn a mapping between the amino acid sequence of a protein and its subcellular localization. The network takes the protein sequence as input and outputs a probability distribution over the different subcellular locations, such as the nucleus, cytoplasm, or membrane. The network is trained on a large dataset of protein sequences and their corresponding localizations, and it learns to recognize the features of the sequence that are important for predicting localization.\nDeepLoc has been shown to be effective in predicting the localization of proteins in various organisms, including bacteria, yeast, and humans. It has also been used to predict the localization of proteins in different cellular compartments, such as the endoplasmic reticulum and the mitochondria.\nOverall, DeepLoc is a powerful tool for predicting protein subcellular localization using deep learning, and it has the potential to be used in a wide range of applications, including drug discovery and personalized medicine."
  },
  {
    "id": 2634,
    "user_query": "What is MULTOVL?",
    "llama-2-7b-chat-hf_response": "MULTOVL is a protein that is involved in the regulation of gene expression, specifically in the context of DNA damage response. It is a multi-functional protein that can act as a transcriptional coactivator, a DNA-binding protein, and a regulator of chromatin structure. MULTOVL is composed of multiple domains, including an N-terminal transcriptional activation domain, a central DNA-binding domain, and a C-terminal chromatin-modifying domain. It is involved in the regulation of various cellular processes, including cell cycle progression, DNA repair, and apoptosis, and is implicated in various diseases, including cancer and neurodegenerative disorders."
  },
  {
    "id": 2660,
    "user_query": "Can GDF15 be a biomarker for metformin treatment?",
    "llama-2-7b-chat-hf_response": "Yes, GDF15 (Growth Differentiation Factor 15) has been identified as a potential biomarker for metformin treatment. Studies have shown that GDF15 levels are increased in response to metformin treatment in patients with type 2 diabetes, and that high levels of GDF15 are associated with improved insulin sensitivity and glucose metabolism. Therefore, measuring GDF15 levels in the blood may be a useful way to monitor the effectiveness of metformin treatment and to identify patients who are likely to benefit from this medication."
  },
  {
    "id": 2664,
    "user_query": "Is recursive splicing more common in short introns?",
    "llama-2-7b-chat-hf_response": "Yes, recursive splicing is more common in short introns. Recursive splicing, also known as intron circular splicing, occurs when the same intron is spliced back into the RNA transcript after it has been excised, resulting in the formation of a circular splicing pattern. This type of splicing is more likely to occur in short introns, as the distance between the intron and the exon is shorter, making it easier for the splicing machinery to recognize and re-splice the intron. In contrast, longer introns are less likely to undergo recursive splicing due to the longer distance between the intron and the exon, which makes it more difficult for the splicing machinery to recognize and re-splice the intron."
  },
  {
    "id": 2679,
    "user_query": "What is the TALE-iD method used for?",
    "llama-2-7b-chat-hf_response": "TALE-iD is a method used for identifying the functional genomics of non-coding RNAs, specifically long non-coding RNAs (lncRNAs). It is a computational approach that uses TALE (transcriptional activator-like effector) nucleases to knockout or knockdown specific lncRNAs in cells and then measures the changes in gene expression to identify the functional effects of the lncRNA. The method allows researchers to identify the functional effects of lncRNAs on gene expression and cellular processes, and can be used to better understand the role of lncRNAs in various biological processes and diseases."
  },
  {
    "id": 2747,
    "user_query": "Which Lisp framework has been developed for image processing?",
    "llama-2-7b-chat-hf_response": "There are several Lisp frameworks that have been developed for image processing, including:\n1. CL-Image: A Lisp library for image processing, providing functions for image manipulation, filtering, and analysis.\n2. ImageTk: A Lisp interface to the Tk image processing toolkit, providing a wide range of image processing functions.\n3. Lisp-Image: A Lisp library for image processing, providing functions for image manipulation, filtering, and analysis, as well as support for multiple image formats.\n4. LispyImage: A Lisp image processing framework that provides a simple and intuitive API for image manipulation and analysis.\n5. Image-Lisp: A Lisp library for image processing, providing functions for image manipulation, filtering, and analysis, as well as support for multiple image formats.\n6. Lisp-Image-Tools: A collection of Lisp functions for image processing, including filtering, resizing, and thresholding.\n7. Image-processing-Lisp: A Lisp library for image processing, providing a wide range of functions for image manipulation and analysis, as well as support for multiple image formats.\n8. Lisp-Image-Processing: A Lisp library for image processing, providing functions for image manipulation, filtering, and analysis, as well as support for multiple image formats.\n9. Image-Lisp-Toolkit: A Lisp toolkit for image processing, providing a set of functions for image manipulation, filtering, and analysis, as well as support for multiple image formats.\n10. Lisp-Image-Workbench: A Lisp environment for image processing, providing a comprehensive set of functions for image manipulation, filtering, and analysis, as well as support for multiple image formats.\nPlease note that this is not an exhaustive list and there may be other Lisp frameworks available for image processing."
  },
  {
    "id": 2759,
    "user_query": "How many genes in S. cerevisiae are the result of an ancient whole genome duplication?",
    "llama-2-7b-chat-hf_response": "The number of genes in Saccharomyces cerevisiae (baker's yeast) that are the result of an ancient whole genome duplication is estimated to be around 100-200. This is a result of a single whole genome duplication event that occurred in the yeast lineage around 1,000-2,000 million years ago. This event, known as the \"yeast whole genome duplication\" (WGD), resulted in the duplication of approximately 50-60% of the yeast genome, including many genes involved in various cellular processes. Since then, there have been multiple rounds of gene loss and gene family expansion, leading to the current gene content of the yeast genome."
  },
  {
    "id": 2763,
    "user_query": "Which complex is bound by estrogen-related receptor β (Esrrb)?",
    "llama-2-7b-chat-hf_response": "Estrogen-related receptor β (Esrrb) is a nuclear receptor that binds to the complex formed by the estrogen response element (EREs) and the DNA. EREs are located in the promoter region of target genes and are recognized by Esrrb, leading to the regulation of gene expression."
  },
  {
    "id": 2842,
    "user_query": "What is the role of ZCCHC17?",
    "llama-2-7b-chat-hf_response": "ZCCHC17 is a zinc finger CCHC-type histone triad-containing protein that plays a role in regulating gene expression by modulating the structure of chromatin, the complex of DNA and proteins that make up the chromosomes. Specifically, ZCCHC17 has been shown to be involved in the regulation of stem cell pluripotency, cell fate determination, and cell proliferation, and is implicated in various diseases such as cancer and developmental disorders."
  },
  {
    "id": 2861,
    "user_query": "Which proteins form the nuclear pore basket in human cells?",
    "llama-2-7b-chat-hf_response": "The nuclear pore basket, also known as the nuclear pore complex (NPC), is composed of several proteins in human cells. The main proteins that form the NPC are:\n1. Nucleoporin 1 (NUP1): Also known as NPM1, this protein is the most abundant component of the NPC and forms the central channel of the structure.\n2. Nucleoporin 2 (NUP2): Also known as NP2, this protein is involved in the formation of the nuclear pore basket and is essential for nuclear transport.\n3. Nucleoporin 3 (NUP3): Also known as NP3, this protein is involved in the formation of the nuclear pore basket and is essential for nuclear transport.\n4. Nucleoporin 4 (NUP4): Also known as NP4, this protein is involved in the formation of the nuclear pore basket and is essential for nuclear transport.\n5. Nucleoporin 5 (NUP5): Also known as NP5, this protein is involved in the formation of the nuclear pore basket and is essential for nuclear transport.\n6. Nucleoporin 6 (NUP6): Also known as NP6, this protein is involved in the formation of the nuclear pore basket and is essential for nuclear transport.\n7. Nucleoporin 7 (NUP7): Also known as NP7, this protein is involved in the formation of the nuclear pore basket and is essential for nuclear transport.\n8. Nucleoporin 8 (NUP8): Also known as NP8, this protein is involved in the formation of the nuclear pore basket and is essential for nuclear transport.\n9. Nucleoporin 9 (NUP9): Also known as NP9, this protein is involved in the formation of the nuclear pore basket and is essential for nuclear transport.\n10. Nucleoporin 10 (NUP10): Also known as NP10, this protein is involved in the formation of the nuclear pore basket and is essential for nuclear transport.\nThese proteins work together to form a complex that spans the nuclear envelope and regulates the transport of molecules between the nucleus and the cytoplasm."
  },
  {
    "id": 2919,
    "user_query": "What type of topoisomerase inhibitor is gepotidacin?",
    "llama-2-7b-chat-hf_response": "Gepotidacin is a topoisomerase II inhibitor. Specifically, it is a topotecan analog that selectively binds to and inhibits the activity of topoisomerase II alpha (Topo IIα), which is involved in DNA replication and repair."
  },
  {
    "id": 2943,
    "user_query": "Describe Canvas SPW",
    "llama-2-7b-chat-hf_response": "Canvas SPW (Spatially-aware Processing Workbench) is a software platform designed to enable the development and execution of spatially-aware applications in various domains, including biology, physics, and computer vision. It provides a set of tools and libraries for processing and analyzing spatial data, as well as a programming environment for creating and executing spatially-aware algorithms.\nHere are some key features of Canvas SPW:\n1. Spatial Data Processing: Canvas SPW provides a range of tools for processing and analyzing spatial data, including filtering, transforming, and visualizing data.\n2. Spatial Operations: The platform includes a set of spatial operations, such as distance calculations, spatial matching, and spatial join, that can be used to perform complex spatial analysis.\n3. Programming Environment: Canvas SPW provides a programming environment for creating and executing spatially-aware algorithms. Developers can write code in a variety of programming languages, including Python, Java, and C++, and use the platform's spatial libraries to perform spatial operations.\n4. Integration with Other Tools: Canvas SPW can be integrated with other tools and platforms, such as Jupyter Notebook, Matplotlib, and R, allowing developers to use the platform in conjunction with their existing workflows.\n5. Scalability: Canvas SPW is designed to be scalable, allowing it to handle large datasets and complex spatial analysis tasks.\n6. Flexibility: The platform provides a flexible and modular architecture, allowing developers to customize the platform to meet their specific needs.\n7. Documentation: Canvas SPW provides detailed documentation and tutorials, making it easy for developers to get started with the platform and understand its capabilities.\nIn summary, Canvas SPW is a powerful platform for developing and executing spatially-aware applications in a variety of domains. Its ability to process and analyze spatial data, combined with its programming environment and integration with other tools, make it a valuable tool for researchers and developers working in the field of spatial analysis."
  },
  {
    "id": 2960,
    "user_query": "List STING agonists.",
    "llama-2-7b-chat-hf_response": "STING (Stimulator of Interferon Genes) is a protein that plays a crucial role in the innate immune response to viral infections. STING agonists are substances that activate the STING protein and trigger an immune response. Here are some examples of STING agonists:\n1. CpG DNA: CpG dinucleotides are found in the genomes of many bacteria and viruses, and they are recognized by STING as a sign of infection. CpG DNA is a common STING agonist used in cancer immunotherapy.\n2. Poly(dA:dT) oligonucleotides: Poly(dA:dT) oligonucleotides are synthetic oligonucleotides that contain repeating sequences of adenine and thymine. They are also recognized by STING and can stimulate an immune response.\n3. Small molecule agonists: Several small molecules have been identified as STING agonists, including the drugs cyclic dinucleotides (CDNs) and imidazoquinoline derivatives. These molecules can activate STING and stimulate an immune response.\n4. Viral proteins: Some viral proteins, such as the poxvirus protein K3L, can inhibit the activity of STING and prevent it from stimulating an immune response.\n5. DNA damage: DNA damage can also activate STING and stimulate an immune response. This is because STING is involved in the response to DNA damage, and it can recognize and respond to breaks in DNA.\nIt's worth noting that STING agonists can have different effects on different cell types and tissues, and their effects can vary depending on the context in which they are used."
  },
  {
    "id": 2964,
    "user_query": "Describe SLIC-CAGE",
    "llama-2-7b-chat-hf_response": "SLIC-CAGE (Slicing-based Chromatin Accessibility and Genome Editing) is a genome engineering technology that combines two main components:\n1. Slicing: SLIC-CAGE uses the CRISPR-Cas13 system to cleave specific genomic regions, creating a \"sliced\" chromatin structure. This slicing event is specific to the targeted genomic region and does not affect the rest of the genome.\n2. CAGE: After slicing, the SLIC-CAGE system introduces a CAGE (Chromatin Accessibility and Genome Editing) domain, which is a specific DNA-binding protein that recognizes and binds to the sliced chromatin. This binding event opens up the chromatin structure, allowing for the recruitment of other proteins that can modify or repair the DNA.\nBy combining these two components, SLIC-CAGE enables precise and efficient editing of specific genomic regions, with minimal off-target effects. This technology has the potential to revolutionize the field of genome engineering and has already shown promising results in various applications, including gene therapy and gene editing."
  },
  {
    "id": 2978,
    "user_query": "What are the roles of LEM-3?",
    "llama-2-7b-chat-hf_response": "LEM-3 (LEM-motif protein 3) is a protein that plays several roles in the cell, including:\n1. Chromatin remodeling: LEM-3 is involved in the remodeling of chromatin structure, particularly in the regulation of gene expression during cell differentiation and development.\n2. Transcriptional elongation: LEM-3 interacts with the transcriptional elongation complex and regulates the processivity of RNA polymerase II.\n3. DNA repair: LEM-3 is involved in the repair of DNA double-strand breaks, particularly through its interaction with the DNA repair protein, 53BP1.\n4. Cell cycle regulation: LEM-3 regulates the G1/S checkpoint and the progression of the cell cycle, particularly through its interaction with the retinoblastoma protein (Rb).\n5. Apoptosis: LEM-3 has been shown to promote apoptosis (programmed cell death) in response to DNA damage and other stimuli."
  },
  {
    "id": 2992,
    "user_query": "List the releases of tmVar",
    "llama-2-7b-chat-hf_response": "As a helpful assistant, I'm happy to provide you with the releases of the tmVar tool:\n1. tmVar 1.0: This was the initial release of the tool, which provided a basic implementation of the variaent calling pipeline.\n2. tmVar 1.2: This release added support for multiple reference genomes and improved the accuracy of the variant calling process.\n3. tmVar 2.0: This major release introduced a new algorithm for calling variants that incorporated additional information about the genome and the sample being analyzed. This release also improved the speed and scalability of the tool.\n4. tmVar 2.1: This release added support for calling variants in non-coding regions of the genome and improved the accuracy of the variant calling process.\n5. tmVar 3.0: This major release introduced a new, more accurate variant calling algorithm that incorporated advanced methods for identifying and filtering variants. This release also improved the speed and scalability of the tool.\n6. tmVar 3.1: This release added support for calling variants in complex genomes and improved the accuracy of the variant calling process.\n7. tmVar 4.0: This major release introduced a new, more accurate variant calling algorithm that incorporated advanced methods for identifying and filtering variants. This release also improved the speed and scalability of the tool.\n8. tmVar 4.1: This release added support for calling variants in non-coding regions of the genome and improved the accuracy of the variant calling process.\n9. tmVar 5.0: This major release introduced a new, more accurate variant calling algorithm that incorporated advanced methods for identifying and filtering variants. This release also improved the speed and scalability of the tool.\n10. tmVar 5.1: This release added support for calling variants in complex genomes and improved the accuracy of the variant calling process.\nThese are the major releases of the tmVar tool, but there may be other updates and bug fixes that have been made to the tool over time."
  },
  {
    "id": 3018,
    "user_query": "Which is the database of somatic mutations in normal cells?",
    "llama-2-7b-chat-hf_response": "There are several databases of somatic mutations in normal cells, including:\n1. The Cancer Genome Atlas (TCGA): TCGA is a collaborative effort between the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) that aims to catalogue the genomic changes in various types of cancer. TCGA has generated comprehensive datasets of somatic mutations in normal tissues, including those from the brain, breast, colon, lung, and other organs.\n2. The 1000 Genomes Project: The 1000 Genomes Project is an international collaboration that aimed to generate a detailed catalogue of genetic variation in the human population. The project included whole-genome sequencing of thousands of individuals, including samples from normal tissues.\n3. The ExAC (Expert Analysis of Genetic Variation) database: ExAC is a comprehensive database of genetic variation in the human population, including both common and rare variants. The database includes data from a variety of sources, including whole-genome sequencing, exome sequencing, and genotyping arrays.\n4. The GTEx (Genotype-Tissue Expression) database: GTEx is a database of genetic and gene expression data from a large number of human tissues, including normal tissues. The database includes whole-genome sequencing and gene expression data from over 500 individuals, as well as detailed information on the tissue sources and processing methods used.\n5. The Roadmap Epigenomics Project: The Roadmap Epigenomics Project is a large-scale effort to map the epigenetic landscape of the human genome. The project includes comprehensive datasets of DNA methylation and histone modification in a wide range of tissues, including normal tissues.\nThese databases provide valuable resources for understanding the somatic mutations that occur in normal cells and how they may contribute to the development of disease."
  },
  {
    "id": 3037,
    "user_query": "Are there graph kernel libraries available implemented in JAVA?",
    "llama-2-7b-chat-hf_response": "Yes, there are several graph kernel libraries available that are implemented in Java. Here are a few examples:\n1. JGraphT: JGraphT is a Java library for graph theory that provides a simple and efficient way to create, manipulate, and analyze graphs. It supports a wide range of graph algorithms and is highly extensible.\n2. Graphiti: Graphiti is a Java library for graph theory that provides a simple and intuitive API for creating, manipulating, and visualizing graphs. It supports a wide range of graph algorithms and is highly customizable.\n3. Gephi: Gephi is a Java library for network data analysis that provides a powerful and flexible platform for working with large-scale graph data. It supports a wide range of graph algorithms and is highly extensible.\n4. Weka: Weka is a Java library for data mining that includes a number of graph-related tools and algorithms. It provides a simple and intuitive API for working with graph data and is highly extensible.\n5. GraphCrunch: GraphCrunch is a Java library for graph processing that provides a simple and efficient way to create, manipulate, and analyze graphs. It supports a wide range of graph algorithms and is highly extensible.\n6. JGraph: JGraph is a Java library for graph theory that provides a simple and efficient way to create, manipulate, and analyze graphs. It supports a wide range of graph algorithms and is highly extensible.\n7. GraphMol: GraphMol is a Java library for molecular graph theory that provides a simple and efficient way to create, manipulate, and analyze molecular graphs. It supports a wide range of graph algorithms and is highly extensible.\n8. JGrapht: JGrapht is a Java library for graph theory that provides a simple and efficient way to create, manipulate, and analyze graphs. It supports a wide range of graph algorithms and is highly extensible.\nThese libraries can be used for a wide range of applications, such as social network analysis, recommendation systems, fraud detection, and more."
  },
  {
    "id": 3045,
    "user_query": "List the four advances integrated into the SHERLOCKv2 platform.",
    "llama-2-7b-chat-hf_response": "The four advances integrated into the SHERLOCKv2 platform are:\n1. Single-molecule sensitivity: SHERLOCKv2 can detect single molecules of the target nucleic acid, significantly improving the sensitivity of the assay compared to previous versions.\n2. Multiplexing: SHERLOCKv2 allows for the detection of multiple targets in a single reaction, enabling the analysis of multiple genomic regions or the detection of multiple viruses or bacteria in a single assay.\n3. Portability: The SHERLOCKv2 platform is designed to be portable and easy to use, making it possible to perform the assay in a variety of settings, including in the field or in resource-limited environments.\n4. Speed: The SHERLOCKv2 platform can perform the assay in a matter of hours, rather than days or weeks, making it possible to quickly identify and respond to genomic threats."
  },
  {
    "id": 3078,
    "user_query": "Describe the bartender algorithm",
    "llama-2-7b-chat-hf_response": "The Bartender algorithm is a heuristic algorithm used in bioinformatics to predict the secondary structure of RNA molecules. It was developed by David Baker and colleagues in 1994.\nThe algorithm works by considering the following factors:\n1. Base pairing: The algorithm uses a set of heuristics to predict the most stable base pairings between nucleotides in the RNA molecule.\n2. Hydrogen bonding: The algorithm takes into account the hydrogen bonding interactions between nucleotides, which can also influence the stability of the RNA structure.\n3. Stacking interactions: The algorithm considers the stacking interactions between the RNA molecule and the surrounding solvent, which can also affect the stability of the structure.\n4. Electrostatic interactions: The algorithm accounts for the electrostatic interactions between the RNA molecule and the surrounding solvent, which can also influence the stability of the structure.\n5. Solvation free energy: The algorithm calculates the solvation free energy of the RNA molecule, which can also affect the stability of the structure.\n6. RNA structure prediction: The algorithm uses a combination of these factors to predict the most stable secondary structure for the RNA molecule.\nThe Bartender algorithm is a simplified version of the more complex and computationally expensive Monte Carlo simulations used to model RNA structure. It is faster and more efficient than Monte Carlo simulations, making it a useful tool for large-scale RNA structure prediction. However, it is not as accurate as Monte Carlo simulations and may not capture all of the subtleties of RNA structure.\nIn summary, the Bartender algorithm is a heuristic algorithm used to predict the secondary structure of RNA molecules based on a set of heuristics that take into account base pairing, hydrogen bonding, stacking interactions, electrostatic interactions, solvation free energy, and RNA structure prediction. It is a useful tool for large-scale RNA structure prediction but may not be as accurate as more complex simulations."
  },
  {
    "id": 3100,
    "user_query": "Which web-based pedigree editors are available?",
    "llama-2-7b-chat-hf_response": "There are several web-based pedigree editors available, including:\n1. Pedigree Online: This is a popular web-based platform that allows users to create and edit family trees, as well as connect with other researchers and share information.\n2. MyHeritage: MyHeritage is a genealogy research platform that offers a web-based pedigree editor, as well as access to historical records and family tree building tools.\n3. FamilySearch: FamilySearch is a free genealogy research platform provided by The Church of Jesus Christ of Latter-day Saints. It offers a web-based pedigree editor, as well as access to historical records and family tree building tools.\n4. GenoPro: GenoPro is a professional genealogy software that offers a web-based pedigree editor, as well as advanced features such as custom reports and charts.\n5. Legacy Family Tree: Legacy Family Tree is a genealogy research platform that offers a web-based pedigree editor, as well as access to historical records and family tree building tools.\n6. FamilyTreeWebinars: FamilyTreeWebinars is a platform that offers web-based genealogy courses and training, as well as a web-based pedigree editor.\n7. GenealogyBank: GenealogyBank is a genealogy research platform that offers a web-based pedigree editor, as well as access to historical records and family tree building tools.\n8. Findmypast: Findmypast is a genealogy research platform that offers a web-based pedigree editor, as well as access to historical records and family tree building tools.\n9. Ancestry: Ancestry is a genealogy research platform that offers a web-based pedigree editor, as well as access to historical records and family tree building tools.\n10. WeRelate: WeRelate is a free and open-source genealogy platform that offers a web-based pedigree editor, as well as access to historical records and family tree building tools."
  },
  {
    "id": 3107,
    "user_query": "Which curated databases exist for spider-venom toxins?",
    "llama-2-7b-chat-hf_response": "There are several curated databases available for spider-venom toxins, including:\n1. ToxinDB: A comprehensive database of toxins from various sources, including spider venoms. It contains information on the structure, function, and pharmacological activities of toxins.\n2. Spider Toxin Database (SpTox): A database of spider venom peptides and proteins, including their sequences, structures, and functional properties.\n3. Venom-DB: A database of venom peptides and proteins from various organisms, including spiders, snakes, and scorpions. It includes information on the molecular properties, biological activities, and evolution of these peptides and proteins.\n4. Natural Products Dictionary (NPD): A database of natural products, including spider venom peptides and proteins, with information on their structures, spectra, and biological activities.\n5. Toxin Ontology (TOX): A database of toxins from various sources, including spider venoms, with information on their structures, functions, and pharmacological activities.\n6. Spider Toxin Information System (STIS): A database of spider venom toxins, including their sequences, structures, and functional properties. It also includes information on the venomous spiders that produce these toxins.\n7. Venomous Animal Toxin Database (VAT): A database of toxins from venomous animals, including spiders, snakes, and scorpions. It includes information on the structure, function, and pharmacological activities of these toxins.\n8. Toxin Central: A database of toxins from various sources, including spider venoms, with information on their structures, functions, and pharmacological activities.\n9. Venom-Tox: A database of venom peptides and proteins from various organisms, including spiders, with information on their structures, functions, and pharmacological activities.\n10. Toxin DataBase (ToxDB): A database of toxins from various sources, including spider venoms, with information on their structures, functions, and pharmacological activities.\nThese databases provide valuable information on the structures, functions, and pharmacological activities of spider-"
  },
  {
    "id": 3111,
    "user_query": "Does Axitinib prolong survival of Pancreatic Cancer patients?",
    "llama-2-7b-chat-hf_response": "Yes, Axitinib has been shown to prolong survival in patients with pancreatic cancer. Axitinib is a tyrosine kinase inhibitor that targets the VEGF receptor 2 (VEGFR2), which is involved in angiogenesis, the process of forming new blood vessels that feed tumor growth. By inhibiting VEGFR2, Axitinib can reduce the formation of new blood vessels in the tumor, leading to a decrease in tumor growth and progression.\nSeveral clinical trials have demonstrated the efficacy and safety of Axitinib in the treatment of pancreatic cancer. For example, a phase III clinical trial published in the New England Journal of Medicine in 2018 found that Axitinib plus gemcitabine improved overall survival compared to gemcitabine alone in patients with metastatic pancreatic cancer. The median overall survival was 11.1 months in the Axitinib arm versus 9.1 months in the gemcitabine arm, representing a 20% improvement in survival.\nAdditionally, a phase II clinical trial published in the Journal of Clinical Oncology in 2017 found that Axitinib monotherapy was effective in patients with advanced pancreatic cancer, with an overall response rate of 11.4% and a median progression-free survival of 4.6 months.\nWhile these results are promising, it is important to note that Axitinib is not a cure for pancreatic cancer, and more research is needed to determine its long-term efficacy and optimal use in clinical practice."
  },
  {
    "id": 3113,
    "user_query": "Through which protein interaction does MLP regulate F-actin dynamics?",
    "llama-2-7b-chat-hf_response": "MLP (Microtubule-associated protein) regulates F-actin dynamics through its interaction with actin-related protein 2/3 complex (ARP2/3 complex). The MLP protein binds to the ARP2/3 complex and inhibits its activity, thereby regulating the dynamics of F-actin."
  },
  {
    "id": 3125,
    "user_query": "How many pseudokinases are there in the human kinome?",
    "llama-2-7b-chat-hf_response": "The number of pseudokinases in the human kinome is not a fixed number and can vary depending on the source and method of classification. However, according to a recent study published in the journal Nature Communications, there are approximately 100-150 pseudokinases in the human kinome. These pseudokinases are proteins that have some of the structural features of kinases but do not have the ability to transfer phosphate groups to other proteins. They are thought to play a role in various cellular processes, including cell signaling and regulation of protein activity."
  },
  {
    "id": 3139,
    "user_query": "List 3 apoE mimetics.",
    "llama-2-7b-chat-hf_response": "ApoE mimetics are compounds that mimic the structure and function of apolipoprotein E (apoE), a protein involved in lipid metabolism and cholesterol transport. Here are three examples of apoE mimetics:\n1. ApoEMimetic-101: This is a small molecule apoE mimetic that has been shown to increase HDL (high-density lipoprotein) cholesterol levels and improve insulin sensitivity in animal models.\n2. CERC-001: This is a synthetic peptide-based apoE mimetic that has been shown to reduce liver triglyceride levels and improve glucose tolerance in animal models of non-alcoholic fatty liver disease (NAFLD).\n3. Glybera: This is a recombinant apoE mimetic that has been approved for use in humans as a gene therapy for the treatment of familial chylomicronemia syndrome, a rare genetic disorder characterized by abnormally high levels of triglycerides in the blood."
  },
  {
    "id": 3140,
    "user_query": "What are there sex differences in SAMHD1 activity?",
    "llama-2-7b-chat-hf_response": "SAMHD1 (Same Deoxyribonuclease 1) is an enzyme that plays a crucial role in regulating the innate immune response to viral infections. There are sex differences in SAMHD1 activity, with studies suggesting that females have higher levels of SAMHD1 activity compared to males.\nFor example, one study found that female mice have higher levels of SAMHD1 activity in their peripheral blood mononuclear cells compared to males, which may contribute to their increased resistance to viral infections. Another study found that female human cells have higher levels of SAMHD1 activity compared to male cells, which may also contribute to their increased resistance to viral infections.\nThese sex differences in SAMHD1 activity may be due to a variety of factors, including differences in the expression of genes involved in the SAMHD1 pathway, differences in the activity of hormones that regulate the SAMHD1 pathway, or differences in the metabolism of SAMHD1 itself.\nOverall, these sex differences in SAMHD1 activity may have important implications for our understanding of the immune response to viral infections and may help to explain why females tend to be less susceptible to certain viral infections than males."
  },
  {
    "id": 3205,
    "user_query": "Does RUNX2 inhibit astrocyte differentiation?",
    "llama-2-7b-chat-hf_response": "Yes, RUNX2 (Runt-related transcription factor 2) has been shown to inhibit the differentiation of astrocytes. RUNX2 is a transcription factor that plays a crucial role in the regulation of cell fate decisions, including the differentiation of neural progenitor cells into astrocytes. Studies have shown that RUNX2 inhibits the expression of genes involved in astrocyte differentiation and functions, leading to a decrease in the number of astrocytes in the brain."
  },
  {
    "id": 3209,
    "user_query": "Where, in the body, would the Cobb-Stainsby excision arthroplasty be performed?",
    "llama-2-7b-chat-hf_response": "The Cobb-Stansby excision arthroplasty is a surgical procedure that is typically performed in the knee joint. Specifically, it is an excision arthroplasty of the medial femoral condyle (MFC) of the knee joint. The procedure involves removing a portion of the damaged or arthritic bone on the inside of the knee joint, and replacing it with an implant or prosthesis. The goal of the procedure is to relieve pain and improve knee function in patients with advanced knee osteoarthritis."
  },
  {
    "id": 3243,
    "user_query": "Does GRHL2 over-expression lead to EMT?",
    "llama-2-7b-chat-hf_response": "Yes, over-expression of GRHL2 has been shown to promote epithelial-to-mesenchymal transition (EMT) in various cell types, including cancer cells. EMT is a process by which epithelial cells lose their cell-cell adhesion and gain mesenchymal characteristics, such as increased migration and invasiveness. Over-expression of GRHL2 has been shown to activate key transcription factors involved in EMT, such as ZEB1 and Snail, and to promote the expression of mesenchymal genes, such as vimentin and N-cadherin. Therefore, GRHL2 over-expression can contribute to the development of a more aggressive and invasive tumor phenotype."
  },
  {
    "id": 3254,
    "user_query": "Which T-UCRs have been implicated in lung cancer?",
    "llama-2-7b-chat-hf_response": "T-UCRs (tumor-associated circular RNAs) have been implicated in lung cancer, including:\n1. circRNA000001: This circular RNA is overexpressed in lung cancer tissues and promotes the proliferation and migration of lung cancer cells.\n2. circRNA000002: This circular RNA is also overexpressed in lung cancer tissues and enhances the epithelial-mesenchymal transition (EMT) of lung cancer cells.\n3. circRNA000003: This circular RNA is downregulated in lung cancer tissues and inhibits the proliferation and migration of lung cancer cells.\n4. circRNA000004: This circular RNA is overexpressed in lung cancer tissues and promotes the EMT of lung cancer cells.\n5. circRNA000005: This circular RNA is downregulated in lung cancer tissues and inhibits the proliferation and migration of lung cancer cells.\n6. circRNA000006: This circular RNA is overexpressed in lung cancer tissues and promotes the EMT of lung cancer cells.\n7. circRNA000007: This circular RNA is downregulated in lung cancer tissues and inhibits the proliferation and migration of lung cancer cells.\n8. circRNA000008: This circular RNA is overexpressed in lung cancer tissues and promotes the EMT of lung cancer cells.\n9. circRNA000009: This circular RNA is downregulated in lung cancer tissues and inhibits the proliferation and migration of lung cancer cells.\n10. circRNA000010: This circular RNA is overexpressed in lung cancer tissues and promotes the EMT of lung cancer cells.\nIt's important to note that these are just a few examples of T-UCRs that have been implicated in lung cancer, and further research is needed to fully understand the role of these circular RNAs in lung cancer development and progression."
  },
  {
    "id": 3268,
    "user_query": "What is known about the orphan receptor GPR151?",
    "llama-2-7b-chat-hf_response": "GPR151 (G protein-coupled receptor 151) is an orphan receptor, meaning that it does not have a well-defined endogenous ligand or a clear physiological function. However, recent studies have shed light on its potential role in various biological processes. Here are some key findings:\n1. GPR151 is a seven-transmembrane receptor that is primarily expressed in the brain, specifically in regions involved in regulating energy homeostasis, such as the hypothalamus and brainstem.\n2. GPR151 has been shown to play a role in the regulation of glucose metabolism. Studies have shown that GPR151 activation increases glucose uptake in adipocytes and skeletal muscle cells, while GPR151 inhibition leads to impaired glucose tolerance and insulin sensitivity.\n3. GPR151 has also been implicated in the regulation of body weight and energy balance. Studies have shown that GPR151 activation leads to decreased food intake and body weight, while GPR151 inhibition leads to increased food intake and body weight gain.\n4. GPR151 has been linked to the regulation of inflammation and immune response. Studies have shown that GPR151 activation inhibits the production of pro-inflammatory cytokines, while GPR151 inhibition leads to increased inflammation.\n5. GPR151 has been shown to play a role in the regulation of neurotransmission and synaptic plasticity. Studies have shown that GPR151 activation enhances synaptic transmission and learning, while GPR151 inhibition leads to impaired synaptic plasticity and cognitive function.\nOverall, while GPR151 was once considered an orphan receptor with no clear function, recent studies have shown that it plays a complex and multifaceted role in various physiological processes, including glucose metabolism, energy homeostasis, inflammation, immune response, and neurotransmission. Further research is needed to fully understand the mechanisms of GPR151 and its potential as a therapeut"
  },
  {
    "id": 3285,
    "user_query": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine.",
    "llama-2-7b-chat-hf_response": "The Fluzone intradermal quadrivalent vaccine contains the following attenuated live viruses:\n* FluA: A/H1N1 (Pandemrix)\n* FluB: B/Victoria\n* FluA: A/H3N2 (Severe Florida)\n* FluB: B/Brisbane\nPlease note that the specific viruses contained in each vaccine may vary depending on the manufacturer and the year of production. It's always best to consult the vaccine's package insert or the manufacturer's website for the most up-to-date information."
  },
  {
    "id": 3345,
    "user_query": "Which part of the TNFR2 gene is genetically associated with Systemic Lupus Erythematosus?",
    "llama-2-7b-chat-hf_response": "The TNFR2 gene is genetically associated with Systemic Lupus Erythematosus (SLE) in the promoter region. Specifically, a genetic variation in the -174G>C polymorphism in the promoter region of the TNFR2 gene has been found to be associated with an increased risk of developing SLE."
  },
  {
    "id": 3353,
    "user_query": "Is there a vaccine for peanut allergy?",
    "llama-2-7b-chat-hf_response": "There is currently no licensed vaccine available for the prevention of peanut allergy. However, researchers are actively working on developing a peanut allergy vaccine, and several clinical trials are underway to evaluate its safety and efficacy.\nOne of the most promising approaches is to use a modified form of the peanut protein, called Peanut Allergen Powder (PAP), as a vaccine. PAP is made by grinding peanuts into a fine powder and removing the allergenic proteins using a process called protein purification. The resulting powder is then formulated with adjuvants, such as aluminum salts, to enhance the immune response.\nSeveral clinical trials have shown that PAP can stimulate an immune response in individuals with peanut allergy, and some have reported significant improvements in symptoms and tolerance to peanut exposure. However, it is important to note that these trials have been small and had limited follow-up periods, so more research is needed to confirm the long-term safety and efficacy of the vaccine.\nOther approaches to developing a peanut allergy vaccine include using peanut extracts or recombinant peanut proteins, as well as targeting different immune cells or mechanisms to enhance the immune response. However, these approaches are still in the early stages of development and have not yet been tested in humans.\nOverall, while there is currently no licensed vaccine available for peanut allergy, researchers are actively working on developing new treatments to help manage this common and potentially life-threatening condition."
  },
  {
    "id": 3365,
    "user_query": "What is particular about the mouse Fxy gene's chromosomal position?",
    "llama-2-7b-chat-hf_response": "The mouse Fxy gene is located on the X chromosome at position Xp11.2."
  },
  {
    "id": 3397,
    "user_query": "What is the basis of the methidiumpropyl-EDTA sequencing (MPE-seq) method?",
    "llama-2-7b-chat-hf_response": "The basis of the MPE-seq method is the use of a reagent called methidiumpropyl-EDTA (methidium-EDTA) to selectively label and capture RNA molecules in a sample. The method is based on the reaction of methidium-EDTA with RNA, which results in the formation of a stable, fluorescently labeled complex that can be separated from other molecules in the sample using a variety of methods, such as gel electrophoresis or mass spectrometry.\nThe MPE-seq method is a form of RNA sequencing that allows for the simultaneous analysis of multiple RNA molecules in a single reaction, without the need for prior knowledge of the RNA transcripts present in the sample. It has been used to study a wide range of biological processes, including gene expression, RNA splicing, and RNA editing.\nThe basic steps of the MPE-seq method are as follows:\n1. Sample preparation: The sample is prepared by treating it with methidium-EDTA, which selectively labels and captures RNA molecules.\n2. Separation: The labeled RNA molecules are separated from other molecules in the sample using a variety of methods, such as gel electrophoresis or mass spectrometry.\n3. Detection: The labeled RNA molecules are detected using a variety of methods, such as fluorescence microscopy or high-resolution melting analysis.\n4. Data analysis: The resulting data is analyzed to identify and quantify the RNA molecules present in the sample.\nThe MPE-seq method has several advantages over other RNA sequencing methods, including its simplicity, sensitivity, and ability to analyze multiple RNA molecules in a single reaction. It is also relatively inexpensive and can be performed using standard laboratory equipment, making it a valuable tool for researchers in a variety of fields."
  },
  {
    "id": 3400,
    "user_query": "Which programming language has been used for implementing GWAR?",
    "llama-2-7b-chat-hf_response": "GWAR (Genome-Wide Association Study) is typically implemented using a variety of programming languages depending on the specific requirements and the preferences of the researcher. However, some popular programming languages used for GWAS analysis include:\n1. R: R is a popular programming language for statistical computing and graphics, and is widely used in the bioinformatics community for GWAS analysis. R packages such as PLINK, GCTA, and SNPTEST provide functions for conducting GWAS.\n2. Python: Python is a versatile language that is widely used in bioinformatics and genomics. Libraries such as scikit-learn, scipy, and pandas provide functions for data manipulation and analysis, while libraries such as GWASpy and PySnp provide functions specifically for GWAS.\n3. MATLAB: MATLAB is a programming language and environment specifically designed for scientific computing and data analysis. It is commonly used for GWAS analysis due to its ability to handle large datasets and perform complex statistical analyses.\n4. SAS: SAS (Statistical Analysis System) is a software suite that is widely used in the statistics and bioinformatics communities for data analysis. It provides a range of tools for GWAS analysis, including the GENABEL and PLINK procedures.\nUltimately, the choice of programming language will depend on the specific requirements of the analysis and the researcher's familiarity with the language."
  },
  {
    "id": 3406,
    "user_query": "Does xaliproden improve prognosis of amyotrophic lateral sclerosis?",
    "llama-2-7b-chat-hf_response": "Xaliproden (also known as verubecestat) is a drug that has been investigated for the treatment of amyotrophic lateral sclerosis (ALS), but its effect on the prognosis of the disease is still unknown.\nThere have been some clinical trials conducted to evaluate the safety and efficacy of xaliproden in ALS patients, but the results have been mixed and inconclusive.\nA phase II clinical trial published in 2019 found that xaliproden did not meet the primary endpoint of slowing the progression of ALS compared to placebo. However, the study did show that xaliproden was associated with a slower decline in cognitive function compared to placebo.\nAnother phase III clinical trial, also published in 2019, found that xaliproden did not meet the primary endpoint of slowing the progression of ALS compared to the drug riluzole, which is the current standard of care for ALS. However, the study did show that xaliproden was associated with a slower decline in motor function compared to riluzole in some subgroups of patients.\nOverall, while the evidence is still emerging and inconclusive, some studies suggest that xaliproden may have a potential therapeutic effect on the progression of ALS, particularly in certain subgroups of patients. However, more research is needed to confirm these findings and establish the safety and efficacy of xaliproden for the treatment of ALS."
  },
  {
    "id": 3410,
    "user_query": "In which chromosome are transgenes inserted in the case of the LiPS-A3S line?",
    "llama-2-7b-chat-hf_response": "The LiPS-A3S line is a transgenic line in which the transgene is inserted into chromosome 16."
  },
  {
    "id": 3430,
    "user_query": "Which tool exist for predicting drug synergy with deep learning?",
    "llama-2-7b-chat-hf_response": "There are several deep learning tools and models that can be used for predicting drug synergy, including:\n1. DeepDrug: This is a deep learning model that predicts drug synergy by analyzing the protein-protein interaction networks of drugs and their targets.\n2. DrugSynth: This model uses a deep learning architecture to predict drug synergy by analyzing the chemical structures of drugs and their targets.\n3. DrugNet: This model predicts drug synergy by analyzing the protein-protein interaction networks of drugs and their targets, as well as the drug's chemical structure.\n4. DeepChem: This is a deep learning model that predicts drug synergy by analyzing the chemical structure of drugs and their targets.\n5. DrugBank: This is a comprehensive database of drugs and their targets, which can be used to predict drug synergy using deep learning models.\n6. ChEA-2017: This is a deep learning model that predicts drug synergy by analyzing the chemical structure of drugs and their targets, as well as the gene expression profiles of cancer cells.\n7. DrugDiscovery: This is a deep learning model that predicts drug synergy by analyzing the chemical structure of drugs and their targets, as well as the protein-protein interaction networks of drugs and their targets.\n8. DrugTarget: This is a deep learning model that predicts drug synergy by analyzing the protein-protein interaction networks of drugs and their targets, as well as the drug's chemical structure.\n9. DrugCombination: This is a deep learning model that predicts drug synergy by analyzing the chemical structure of drugs and their targets, as well as the protein-protein interaction networks of drugs and their targets.\n10. DrugTox: This is a deep learning model that predicts drug synergy by analyzing the chemical structure of drugs and their targets, as well as the toxicity profiles of drugs.\nIt's worth noting that these are just a few examples of the many deep learning models and tools available for predicting drug synergy, and the choice of which one to use will depend on the specific research question and data available."
  },
  {
    "id": 3433,
    "user_query": "Which cloud-based platform has been developed for comparing GWAS?",
    "llama-2-7b-chat-hf_response": "The cloud-based platform that has been developed for comparing GWAS is called \"GWAScloud\". GWAScloud is an open-source platform that allows researchers to compare genetic association signals across different GWAS datasets, and to identify shared signals and patterns of association. It was developed by the University of California, San Diego, and is available for use by researchers worldwide."
  },
  {
    "id": 3434,
    "user_query": "Can CMB305 be used against sarcomas?",
    "llama-2-7b-chat-hf_response": "Yes, CMB305 has been shown to be effective against sarcomas in preclinical studies. CMB305 is a bispecific antibody that targets both CD3 and CD138, which are expressed on the surface of multiple myeloma cells, including some sarcomas. The antibody is designed to recruit T cells to the site of the tumor and stimulate an immune response against the cancer cells. In preclinical studies, CMB305 has shown activity against various types of sarcomas, including osteosarcoma and chondrosarcoma."
  },
  {
    "id": 3461,
    "user_query": "What are manifestations of the Saint's Triad?",
    "llama-2-7b-chat-hf_response": "The Saint's Triad, also known as the Ehlers-Danlos Syndrome (EDS), is a group of connective tissue disorders that affect the body's collagen production and structure. The manifestations of the Saint's Triad can vary in severity and may include:\n1. Hypermobility: Joints that are overly flexible and can move beyond their normal range of motion.\n2. Skin hyperextensibility: Skin that stretches further than normal and can tear easily.\n3. Tissue fragility: Weakened connective tissue that can lead to bruising, bleeding, and other injuries.\nThese manifestations can affect various parts of the body, including the joints, skin, and internal organs. Some individuals with the Saint's Triad may also experience other symptoms, such as chronic pain, fatigue, and gastrointestinal issues."
  },
  {
    "id": 3470,
    "user_query": "Is overexpression of LY6K associated with better prognosis for non-small cell lung cancer patients?",
    "llama-2-7b-chat-hf_response": "Yes, overexpression of LY6K has been associated with better prognosis for non-small cell lung cancer (NSCLC) patients. Studies have shown that high levels of LY6K expression are associated with improved overall survival, disease-free survival, and response to chemotherapy in NSCLC patients."
  },
  {
    "id": 3473,
    "user_query": "List Cdk targets that are dephosphorylated during cytokinesis",
    "llama-2-7b-chat-hf_response": "During cytokinesis, the cell cycle regulator Cdk (cyclin-dependent kinase) is inhibited by phosphorylation, leading to the dephosphorylation of its targets. Some of the known Cdk targets that are dephosphorylated during cytokinesis include:\n1. Cdk1: Cdk1 is inhibited by phosphorylation by the Fyzzy protein during cytokinesis, leading to the dephosphorylation of its targets.\n2. Cdk2: Cdk2 is also inhibited by phosphorylation during cytokinesis, leading to the dephosphorylation of its targets.\n3. Cdk4: Cdk4 is inhibited by phosphorylation during cytokinesis, leading to the dephosphorylation of its targets.\n4. Cdk5: Cdk5 is inhibited by phosphorylation during cytokinesis, leading to the dephosphorylation of its targets.\n5. Cdk6: Cdk6 is inhibited by phosphorylation during cytokinesis, leading to the dephosphorylation of its targets.\n6. Cdk7: Cdk7 is inhibited by phosphorylation during cytokinesis, leading to the dephosphorylation of its targets.\n7. Cdk9: Cdk9 is inhibited by phosphorylation during cytokinesis, leading to the dephosphorylation of its targets.\n8. Mks1: Mks1 is a downstream target of Cdk5 and is inhibited by phosphorylation during cytokinesis.\n9. N-Ras: N-Ras is a downstream target of Cdk4 and is inhibited by phosphorylation during cytokinesis.\n10. Scrib: Scrib is a downstream target of Cdk1 and is inhibited by phosphorylation during cytokinesis.\nThese dephosphorylation events are important for the proper progression of cytokinesis, as they allow the cell to transition from the G2 phase of the cell cycle to the M phase, where the cell can undergo mitosis and complete cell division."
  },
  {
    "id": 3508,
    "user_query": "What is Xanamem?",
    "llama-2-7b-chat-hf_response": "Xanamem is a drug that inhibits the activity of the enzyme protein kinase C (PKC). PKC is involved in a variety of cellular processes, including cell signaling, metabolism, and cell growth, and is implicated in a number of diseases, including cancer and neurodegenerative disorders. Xanamem is being investigated as a potential therapeutic agent for the treatment of these diseases, as well as for the treatment of cancer."
  },
  {
    "id": 3520,
    "user_query": "What is the role of the Hof1-Cyk3 interaction in yeast?",
    "llama-2-7b-chat-hf_response": "In yeast, the interaction between Hof1 and Cyk3 plays a crucial role in regulating the cell's response to oxidative stress. Hof1 is a protein that helps to maintain genome stability by repairing DNA damage, while Cyk3 is a protein that helps to regulate the cell's redox state. The interaction between these two proteins helps to coordinate the cell's response to oxidative stress by allowing Hof1 to be activated in response to changes in the cell's redox state. This allows the cell to better protect itself against DNA damage and maintain genome stability."
  },
  {
    "id": 3598,
    "user_query": "Which T-UCRs have been implicated in gastric cancer?",
    "llama-2-7b-chat-hf_response": "T-bet (T-box transcription factor Eomesodermin) and Eomesodermin (Eomes) are T-UCRs that have been implicated in gastric cancer."
  },
  {
    "id": 3607,
    "user_query": "What is the Lupus Severity Index (LSI)?",
    "llama-2-7b-chat-hf_response": "The Lupus Severity Index (LSI) is a clinical index used to assess the severity of systemic lupus erythematosus (SLE), a chronic autoimmune disease that can affect multiple organ systems. The LSI is a composite measure that takes into account various clinical and laboratory parameters, including:\n1. Physical examination findings, such as rash, joint swelling, and organ involvement.\n2. Laboratory test results, including levels of autoantibodies, complement components, and inflammatory markers.\n3. Disease activity scores, such as the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) or the Lupus Activity Survey (LAS).\n4. Patient-reported outcomes, such as pain, fatigue, and quality of life.\nThe LSI is calculated by assigning weights to each of these parameters based on their relative importance in determining disease severity, and then adding the scores for each parameter. The total score on the LSI ranges from 0 to 100, with higher scores indicating greater disease severity. The LSI has been shown to be a useful tool for assessing disease activity and monitoring treatment responses in SLE patients."
  },
  {
    "id": 3615,
    "user_query": "Which disorders are caused by de novo mutations in ZSWIM6?",
    "llama-2-7b-chat-hf_response": "ZSWIM6 is a gene that has been associated with several rare genetic disorders, including:\n1. Zellweger syndrome: ZSWIM6 mutations are a common cause of this severe neonatal syndrome, characterized by hypotonia, developmental delay, and various organ system defects.\n2. Cerebral White Matter Disease (CWMD): Some mutations in ZSWIM6 have been identified in patients with CWMD, a rare genetic disorder characterized by white matter degeneration in the brain.\n3. Intellectual Disability: ZSWIM6 mutations have been found in individuals with intellectual disability, often in combination with other genetic alterations.\n4. Autism Spectrum Disorder (ASD): Some studies have suggested that ZSWIM6 mutations may be associated with an increased risk of autism spectrum disorder (ASD).\n5. Epilepsy: ZSWIM6 mutations have been identified in individuals with epilepsy, particularly those with neonatal-onset epilepsy.\nIt is important to note that these disorders are rare and the frequency of ZSWIM6 mutations in these conditions may vary depending on the population studied."
  },
  {
    "id": 3626,
    "user_query": "Which disease can be classified using the Koos Classification?",
    "llama-2-7b-chat-hf_response": "The Koos Classification is used to classify diseases related to the nervous system, particularly those affecting the brain and spinal cord. It is commonly used to classify neurodegenerative diseases, such as:\n1. Alzheimer's disease\n2. Parkinson's disease\n3. Huntington's disease\n4. Progressive supranuclear palsy\n5. Multiple system atrophy\n6. Corticobasal degeneration\n7. Primary lateral sclerosis\n8. Spinocerebellar ataxia\nThese diseases are characterized by progressive loss of neurons and degeneration of brain tissue, leading to a range of cognitive, motor, and behavioral symptoms. The Koos Classification provides a standardized framework for classifying and diagnosing these diseases, which can help guide treatment and research efforts."
  },
  {
    "id": 3628,
    "user_query": "What are the in vivo effects of AZD8601?",
    "llama-2-7b-chat-hf_response": "AZD8601 is a potent and selective inhibitor of the enzyme PI3K (phosphatidylinositol 3-kinase), which plays a key role in various cellular signaling pathways, including those involved in cell survival, growth, and migration. In vivo, AZD8601 has been shown to have a range of effects, including:\n1. Inhibition of tumor growth: AZD8601 has been shown to inhibit the growth of various types of tumors, including breast, lung, and colon cancer, both in vitro and in vivo.\n2. Induction of apoptosis: AZD8601 can induce apoptosis (programmed cell death) in cancer cells, which can help to slow or stop the growth of tumors.\n3. Inhibition of angiogenesis: AZD8601 can inhibit the formation of new blood vessels, which are essential for the growth and spread of solid tumors.\n4. Enhancement of chemotherapy: AZD8601 can enhance the effects of chemotherapy drugs, such as paclitaxel, in killing cancer cells.\n5. Immune modulation: AZD8601 can modulate the immune response, including the activation of immune cells and the production of cytokines, which can help to combat cancer.\n6. Neuroprotection: AZD8601 has been shown to have neuroprotective effects in animal models of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.\n7. Cardiovascular protection: AZD8601 has been shown to have cardiovascular protective effects in animal models of heart disease, including reducing inflammation and improving cardiac function.\n8. Metabolic protection: AZD8601 has been shown to have metabolic protective effects in animal models of metabolic disorders, including reducing insulin resistance and improving glucose tolerance.\nIt is important to note that the specific in vivo effects of AZD8601 can vary depending on the specific disease or condition being studied, as well as the"
  },
  {
    "id": 3640,
    "user_query": "How are SAHFS created?",
    "llama-2-7b-chat-hf_response": "SAHFs (SWI/SNF-associated histone-fold proteins) are created through a process called \"chromatin remodeling,\" which involves the movement of nucleosomes along DNA strands. This process is mediated by protein complexes called SWI/SNF complexes, which use energy from ATP hydrolysis to move nucleosomes along DNA strands, creating more accessible chromatin structures. As a result, SAHFs are formed through the collective action of multiple SWI/SNF complexes working together to remodel chromatin structures."
  },
  {
    "id": 3672,
    "user_query": "What is the function of the PDZ domain in SATB1?",
    "llama-2-7b-chat-hf_response": "The PDZ (PSD-95, Discs-large, ZO-1) domain is a structural motif found in the SATB1 protein that plays a crucial role in its function. The PDZ domain is involved in the binding of SATB1 to specific protein partners, such as the transcription factor p53, and regulates the localization and activity of these proteins. Specifically, the PDZ domain of SATB1 can interact with the transcriptional activation domain of p53, leading to the suppression of p53-dependent transcription and the regulation of p53 stability. This suggests that the PDZ domain of SATB1 may play a role in regulating the tumor suppressor function of p53 in certain contexts."
  },
  {
    "id": 3678,
    "user_query": "What is the basis of the BLISS technique?",
    "llama-2-7b-chat-hf_response": "The basis of the BLISS (Bias-free Learning of Incremental Support Vector Machines) technique is to address the problem of bias in incremental learning, which can occur when an incremental learning algorithm is trained on a dataset that is not representative of the true distribution of the data. BLISS uses a novel regularization term to encourage the incremental learning algorithm to learn a representation that is robust to changes in the data distribution, and thus avoids bias in the learning process."
  },
  {
    "id": 3679,
    "user_query": "List 3 NK3R antagonists.",
    "llama-2-7b-chat-hf_response": "Here are three known NK3R antagonists:\n1. A-83-01: A potent and selective NK3R antagonist that has been shown to reduce food intake and body weight in animal models of obesity.\n2. BIBN4096: A highly selective and potent NK3R antagonist that has been shown to reduce food intake and body weight in animal models of obesity.\n3. MK-0594: A potent and selective NK3R antagonist that has been shown to reduce food intake and body weight in animal models of obesity."
  },
  {
    "id": 3691,
    "user_query": "Which drug is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects?",
    "llama-2-7b-chat-hf_response": "The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects is called BMS-986177."
  },
  {
    "id": 3693,
    "user_query": "What is the protective efficacy of vaxchora against moderate to severe cholera?",
    "llama-2-7b-chat-hf_response": "Vaxchora, a cholera vaccine made by Sanofi Pasteur, has been shown to provide protection against moderate to severe cholera in clinical trials. The protective efficacy of Vaxchora against moderate to severe cholera has been estimated to be around 70-80% in adults and 50-60% in children, based on the results of Phase 3 clinical trials conducted in Bangladesh, Haiti, and Indonesia. It is important to note that the vaccine does not provide 100% protection against cholera, and it is still possible to contract the disease even after vaccination. Therefore, it is important to continue practicing good hygiene and sanitation practices, such as proper handwashing and water treatment, to reduce the risk of cholera infection."
  },
  {
    "id": 3716,
    "user_query": "Which was the first cholera vaccine approved in the US?",
    "llama-2-7b-chat-hf_response": "The first cholera vaccine approved in the US was the oral cholera vaccine (OCV), also known as the killed oral cholera vaccine, which was approved in 1981 by the Food and Drug Administration (FDA)."
  },
  {
    "id": 3737,
    "user_query": "Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?",
    "llama-2-7b-chat-hf_response": "The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is mutations in the IL21R gene."
  },
  {
    "id": 3743,
    "user_query": "Which is the role of the IFIT1 gene in Systemic Lupus Erythematosus (SLE)?",
    "llama-2-7b-chat-hf_response": "The IFIT1 gene has been found to be mutated in some patients with Systemic Lupus Erythematosus (SLE), a chronic autoimmune disease. The IFIT1 gene encodes for a protein called interferon-induced protein with tetraloop-forming domain 1 (IFIT1), which plays a role in the antiviral response and the regulation of immune cell function.\nMutations in the IFIT1 gene have been associated with an increased risk of developing SLE, as well as with more severe disease manifestations and a higher risk of organ damage. IFIT1 mutations may lead to an imbalance in the immune system, allowing for the overproduction of autoantibodies and the development of autoimmune responses.\nAdditionally, IFIT1 has been shown to be involved in the regulation of the immune response to DNA, and mutations in the IFIT1 gene may affect the ability of the immune system to recognize and respond to DNA from viruses and other foreign molecules, leading to an increased risk of infection and autoimmune diseases.\nOverall, the IFIT1 gene plays a critical role in the regulation of the immune response and its mutation can lead to the development of SLE and other autoimmune diseases."
  },
  {
    "id": 3752,
    "user_query": "What is the use of the Liverpool Elbow Score?",
    "llama-2-7b-chat-hf_response": "The Liverpool Elbow Score (LES) is a patient-reported outcome measure used to assess the severity of elbow symptoms and disability in patients with elbow problems, such as tennis elbow (lateral epicondylitis) or golfer's elbow (medial epicondylitis). The LES assesses the impact of elbow symptoms on daily activities and quality of life, and can be used to monitor the effectiveness of treatment interventions. The score is based on a series of questions that ask patients to rate their level of agreement with statements related to elbow symptoms and function, such as \"I am able to perform my usual activities without pain\" or \"I am unable to perform activities that I enjoy due to my elbow symptoms.\" The LES is a useful tool for clinicians to evaluate the severity of elbow symptoms and to track changes in symptoms over time, as well as to compare outcomes between different treatment groups."
  },
  {
    "id": 3763,
    "user_query": "Describe efforts on Sarcoma from the 100,000 Genomes Project",
    "llama-2-7b-chat-hf_response": "The 100,000 Genomes Project was a major initiative launched in the UK in 2012 to sequence 100,000 human genomes, including those of patients with rare and aggressive cancers such as sarcoma. The project aimed to identify genetic variations associated with these cancers and develop new diagnostic and therapeutic approaches. Here are some key efforts on sarcoma from the 100,000 Genomes Project:\n1. Genomic analysis of sarcoma subtypes: The project analyzed the genomes of over 1,000 sarcoma tumors, including different subtypes such as osteosarcoma, chondrosarcoma, and soft tissue sarcoma. These analyses identified recurrent mutations and copy number alterations that are specific to each subtype.\n2. Identification of new therapeutic targets: The project identified potential therapeutic targets for sarcoma, including genes involved in DNA damage repair, cell cycle regulation, and angiogenesis. These targets could be explored for the development of new sarcoma therapies.\n3. Development of diagnostic tests: The project developed new diagnostic tests for sarcoma based on genetic markers identified in the genomic analysis. These tests could help improve the accuracy of sarcoma diagnosis and enable more targeted and effective treatment.\n4. Improved understanding of sarcoma evolution: The project provided insights into the evolution of sarcoma, including the mechanisms of resistance to chemotherapy and the role of genetic mutations in tumor progression. This knowledge could be used to develop new treatment strategies and improve patient outcomes.\n5. Collaboration with clinical partners: The project collaborated with clinical partners to validate the findings and translate them into clinical practice. This collaboration helped ensure that the research was relevant and useful for patients and clinicians.\nIn summary, the 100,000 Genomes Project has made significant efforts to improve our understanding of sarcoma and develop new diagnostic and therapeutic approaches. The project's findings have the potential to improve patient outcomes and advance the field of sarcoma research."
  },
  {
    "id": 3777,
    "user_query": "Does protein ALEX1 contain armadillo repeats?",
    "llama-2-7b-chat-hf_response": "Yes, protein ALEX1 (Armadillo-like Expressed in Xenopus 1) contains multiple armadillo repeats. Armadillo repeats are a structural motif found in proteins that are involved in protein-protein interactions and are characterized by a conserved pattern of amino acid residues. ALEX1 is a protein that is involved in the regulation of gene expression and contains multiple armadillo repeats in its structure."
  },
  {
    "id": 3789,
    "user_query": "List enzymes that removes histone modifications.",
    "llama-2-7b-chat-hf_response": "Enzymes that remove histone modifications include:\n1. Histone demethylases: These enzymes remove methyl groups from histone proteins, leading to changes in chromatin structure and gene expression. Examples of histone demethylases include KDM5A, KDM5B, and JMJD2A.\n2. Histone acetyltransferases (HATs): These enzymes add acetyl groups to histone proteins, leading to changes in chromatin structure and gene expression. Examples of HATs include p300 and CBP (CREB-binding protein).\n3. Histone deacetylases (HDACs): These enzymes remove acetyl groups from histone proteins, leading to changes in chromatin structure and gene expression. Examples of HDACs include HDAC1, HDAC2, and HDAC6.\n4. Lysine-specific demethylase 1 (LSD1): This enzyme removes methyl groups from histone H3 lysine 4, leading to changes in chromatin structure and gene expression.\n5. Arginine methyltransferases: These enzymes add methyl groups to histone arginine residues, leading to changes in chromatin structure and gene expression. Examples of arginine methyltransferases include PRMT5 and PRMT1.\n6. Prolyl isomerases: These enzymes rearrange the chemical bonds in histone proteins, leading to changes in chromatin structure and gene expression. Examples of prolyl isomerases include PIN1 and PIN2.\n7. Chromodomains-containing proteins: These proteins recognize and bind to specific histone modifications, leading to changes in chromatin structure and gene expression. Examples of chromodomains-containing proteins include CHD1 and CHD4.\n8. Sirtuins: These enzymes remove acetyl groups from histone proteins, leading to changes in chromatin structure and gene expression. Examples of sirtuins include SIRT1 and SIRT6.\n9. Ubiquitin-protein ligases (E3s): These enzymes ubiquitinate histone proteins, leading to changes in chrom"
  },
  {
    "id": 3806,
    "user_query": "Does head ct increase brain tumor risk?",
    "llama-2-7b-chat-hf_response": "Head CT (computed tomography) scans are diagnostic imaging tests that use X-rays to produce detailed cross-sectional images of the brain. While head CT scans are valuable for diagnosing and monitoring various conditions affecting the brain, there is some evidence to suggest that repeated exposure to CT radiation may increase the risk of developing a brain tumor.\nThe International Agency for Research on Cancer (IARC) has classified CT scans as \"possibly carcinogenic to humans,\" based on limited evidence in humans and sufficient evidence in animals. However, it's important to note that the overall risk of developing a brain tumor from a single head CT scan is still relatively low, and the benefits of the test often outweigh the potential risks.\nStudies have suggested that exposure to CT radiation may increase the risk of developing a brain tumor, particularly for children and adolescents, who are more sensitive to radiation. The risk may be higher for people who have had multiple CT scans over time. However, the exact mechanisms by which CT radiation increases the risk of brain tumors are not yet fully understood, and more research is needed to determine the precise risk.\nTo minimize the risks associated with head CT scans, healthcare providers are advised to use the lowest possible dose of radiation necessary to produce diagnostic images, and to consider alternative imaging modalities when possible. Additionally, patients can help reduce their exposure to CT radiation by avoiding unnecessary scans and discussing any concerns they may have with their healthcare provider.\nIn summary, while head CT scans may increase the risk of developing a brain tumor, the overall risk is still relatively low, and the benefits of the test often outweigh the potential risks. However, it's important to be aware of the potential risks and to take steps to minimize exposure to CT radiation."
  },
  {
    "id": 3809,
    "user_query": "Which type of pluripotency is Otx2 associated with?",
    "llama-2-7b-chat-hf_response": "Otx2 is associated with neural pluripotency."
  },
  {
    "id": 3815,
    "user_query": "How many DNaseI hypersensitive sites (DHS) mark the murine beta globin locus region?",
    "llama-2-7b-chat-hf_response": "The murine beta globin locus region has several DNase I hypersensitive sites (DHS), which are regions of chromatin that are more accessible to DNase I digestion due to the lack of nucleosomes or other chromatin structures. The exact number of DHS sites at the murine beta globin locus region can vary depending on the specific method used to identify them, but there are typically several dozen to several hundred DHS sites located throughout the region. Some of the most well-characterized DHS sites at the beta globin locus include:\n1. DHS1: located at the 5' end of the beta globin gene cluster, near the promoter and enhancer elements.\n2. DHS2: located in the intron 1 of the beta globin gene, near the splice site.\n3. DHS3: located in the 3' untranslated region (UTR) of the beta globin gene.\n4. DHS4: located near the polyadenylation site of the beta globin mRNA.\n5. DHS5: located in the intergenic region between the beta globin gene and the alpha globin gene.\n6. DHS6: located in the 5' end of the alpha globin gene.\nThese DHS sites play important roles in regulating the expression of the beta globin gene, including recruiting transcription factors, chromatin remodelers, and other regulatory proteins."
  },
  {
    "id": 3822,
    "user_query": "List as many European influenza vaccines as possible.",
    "llama-2-7b-chat-hf_response": "There are several European influenza vaccines available in the market. Here are some of them:\n1. Fluarix Tetra: This is a quadrivalent vaccine that protects against four strains of influenza: two A strains and two B strains. It is manufactured by GlaxoSmithKline (GSK) and is approved for use in individuals aged 6 months and older.\n2. Fluad: This is a quadrivalent vaccine that protects against four strains of influenza: two A strains and two B strains. It is manufactured by Novartis and is approved for use in individuals aged 65 years and older.\n3. Fluvirin: This is a trivalent vaccine that protects against three strains of influenza: two A strains and one B strain. It is manufactured by Novartis and is approved for use in individuals aged 6 months and older.\n4. Fluzone: This is a trivalent vaccine that protects against three strains of influenza: two A strains and one B strain. It is manufactured by Sanofi Pasteur and is approved for use in individuals aged 6 months and older.\n5. Aggripulse: This is a quadrivalent vaccine that protects against four strains of influenza: two A strains and two B strains. It is manufactured by Sanofi Pasteur and is approved for use in individuals aged 6 months and older.\n6. Vaxigrip: This is a quadrivalent vaccine that protects against four strains of influenza: two A strains and two B strains. It is manufactured by Sanofi Pasteur and is approved for use in individuals aged 6 months and older.\n7. Fluarix: This is a quadrivalent vaccine that protects against four strains of influenza: two A strains and two B strains. It is manufactured by GSK and is approved for use in individuals aged 6 months and older.\n8. Flu-Tetra: This is a quadrivalent vaccine that protects against four strains of influenza: two A strains and two B strains. It is manufactured by Bio-Medica and is approved for use in individuals"
  },
  {
    "id": 3832,
    "user_query": "Is the Paramyxovirus geneome segmented, negative-sense RNA?",
    "llama-2-7b-chat-hf_response": "Yes, the paramyxovirus geneome is segmented, negative-sense RNA. Paramyxoviruses are a family of viruses that include the measles virus, mumps virus, and respiratory syncytial virus (RSV), among others. Their genome is composed of several segments of negative-sense RNA, each of which encodes a different protein. The segments are connected by non-coding regions called introns, and the entire genome is transcribed in a 3' to 5' direction. The negative-sense RNA genome is then translated into protein through a process called transcriptional translation, in which the RNA is first transcribed into a complementary RNA (cRNA) and then translated into protein."
  },
  {
    "id": 3869,
    "user_query": "Roflumilast Cream is effective for which disease?",
    "llama-2-7b-chat-hf_response": "Roflumilast cream is effective for the treatment of psoriasis."
  },
  {
    "id": 3885,
    "user_query": "Which tools have been developed for identifying and visualising ncRNA promoters?",
    "llama-2-7b-chat-hf_response": "Several tools have been developed for identifying and visualizing non-coding RNA (ncRNA) promoters. Here are some of the commonly used tools:\n1. RNAhybrid: This tool uses a combination of sequence and structural information to predict the secondary and tertiary structure of RNA molecules, including ncRNA promoters.\n2. PICTAR: This tool uses a machine learning approach to identify putative promoter regions in ncRNA transcripts based on their sequence features.\n3. Prognosticate: This tool uses a Bayesian framework to predict the location and strength of ncRNA promoters based on their sequence and structural features.\n4. RNAProM: This tool uses a combination of machine learning and structural modeling to predict the promoter regions of ncRNAs.\n5. NCPromoterFinder: This tool uses a combination of sequence and structural features to identify putative promoter regions in ncRNAs.\n6. RNApromoter: This tool uses a machine learning approach to predict the promoter regions of ncRNAs based on their sequence features.\n7. DeepPromoter: This tool uses deep learning techniques to predict the promoter regions of ncRNAs based on their sequence features.\n8. Prodigal: This tool uses a combination of sequence and structural features to predict the location and strength of ncRNA promoters.\n9. RNApromoterFinder: This tool uses a combination of sequence and structural features to identify putative promoter regions in ncRNAs.\n10. NCRNApromoter: This tool uses a machine learning approach to predict the promoter regions of ncRNAs based on their sequence features.\nThese tools can be used to identify and visualize ncRNA promoters in various organisms, including humans, and can help researchers understand the regulatory mechanisms of ncRNA expression."
  },
  {
    "id": 3918,
    "user_query": "List example genes that SWIM tool has identified and which are down-regulated in glioblastoma",
    "llama-2-7b-chat-hf_response": "SWIM (Systematic Workflow for the Identification of Mutational Mechanisms) is a tool that can be used to identify genes that are differentially expressed between two or more conditions, such as a disease state and a normal state. Here are some examples of genes that SWIM has identified as down-regulated in glioblastoma:\n1. TP53: A tumor suppressor gene that is frequently mutated in glioblastoma.\n2. PTEN: A tumor suppressor gene that is frequently mutated or deleted in glioblastoma, leading to increased PI3K signaling.\n3. CDKN2A: A tumor suppressor gene that is frequently mutated or deleted in glioblastoma, leading to increased CDK activity.\n4. STK11: A tumor suppressor gene that is frequently mutated in glioblastoma, leading to increased AKT signaling.\n5. ARID1A: A gene that is frequently mutated in glioblastoma, leading to increased chromatin remodeling and transcriptional regulation.\n6. PIK3R1: A gene that is frequently mutated in glioblastoma, leading to increased PI3K signaling.\n7. MAP3K5: A gene that is frequently mutated in glioblastoma, leading to increased MAPK signaling.\n8. CDKN2B: A tumor suppressor gene that is frequently mutated or deleted in glioblastoma, leading to increased CDK activity.\n9. BRCA1: A tumor suppressor gene that is frequently mutated in glioblastoma, leading to increased DNA repair and transcriptional regulation.\n10. PTENP1: A gene that is frequently mutated in glioblastoma, leading to increased PI3K signaling.\nIt's important to note that the list of genes identified by SWIM may vary depending on the specific dataset used and the parameters set for the analysis. Additionally, the functional impact of each mutation may also vary depending on the context in which it occurs and the other mutations present in the tumor."
  },
  {
    "id": 3926,
    "user_query": "Which R packages have been developed for studying TADs?",
    "llama-2-7b-chat-hf_response": "Several R packages have been developed for studying Topologically Associating Domains (TADs), including:\n1. TADbit: This package provides a comprehensive set of tools for the analysis of TADs, including the detection of TAD boundaries, the analysis of chromatin accessibility, and the identification of TAD-associated genes.\n2. TADtrack: This package allows users to identify and track TADs across different cell types and conditions, and to analyze the dynamics of TADs over time.\n3. TADseq: This package provides a comprehensive workflow for the analysis of TADs in RNA sequencing data, including the detection of TAD-associated genes and the analysis of TAD-specific expression patterns.\n4. TAD-tools: This package provides a collection of tools for the analysis of TADs, including the detection of TAD boundaries, the analysis of chromatin accessibility, and the identification of TAD-associated genes.\n5. ChromHMM: This package provides a framework for the analysis of chromatin structure and TADs, including the prediction of TAD boundaries and the analysis of chromatin accessibility.\n6. TAD-seq-workflow: This package provides a comprehensive workflow for the analysis of TADs in RNA sequencing data, including the detection of TAD-associated genes and the analysis of TAD-specific expression patterns.\n7. TAD-analysis: This package provides a collection of tools for the analysis of TADs, including the detection of TAD boundaries, the analysis of chromatin accessibility, and the identification of TAD-associated genes.\n8. TAD-predict: This package provides a tool for the prediction of TAD boundaries based on chromatin accessibility data.\n9. TAD-detect: This package provides a tool for the detection of TADs in ChIP-seq data.\n10. TAD-profile: This package provides a tool for the analysis of TAD profiles in RNA sequencing data.\nPlease note that this is not an exhaustive list and there are many other R packages available for studying TADs, each with their own specific functions and features."
  },
  {
    "id": 3927,
    "user_query": "Which bioconductor tool has been developed for accessing bacterial regulatory networks?",
    "llama-2-7b-chat-hf_response": "The Bioconductor package \"Rregulon\" has been developed for accessing bacterial regulatory networks."
  },
  {
    "id": 3933,
    "user_query": "What are the end products of the shikimate pathway?",
    "llama-2-7b-chat-hf_response": "The end products of the shikimate pathway are aromatic amino acids, including:\n1. Tyrosine\n2. Tryptophan\n3. Phenylalanine\n4. Tyramine\n5. Histidine\nThese amino acids are important building blocks for various biological molecules, such as proteins, neurotransmitters, and hormones. The shikimate pathway is a metabolic pathway that produces these aromatic amino acids from the amino acid precursor chorismate, which is derived from the breakdown of the amino acid tryptophan."
  },
  {
    "id": 3936,
    "user_query": "Is cabergoline used for treatment of the Nelson's syndrome ?",
    "llama-2-7b-chat-hf_response": "Yes, cabergoline is sometimes used to treat Nelson's syndrome, which is a rare condition that can occur after treatment with dopamine agonists, such as bromocriptine or ropinirole, for conditions such as Parkinson's disease or hyperprolactinemia (elevated prolactin levels). Nelson's syndrome is characterized by the rapid growth of a pituitary tumor after treatment with dopamine agonists, leading to amenorrhea (loss of menstruation), infertility, and other hormonal imbalances. Cabergoline, a dopamine receptor agonist, has been shown to be effective in reducing the size of the pituitary tumor and reversing the hormonal imbalances associated with Nelson's syndrome."
  },
  {
    "id": 3939,
    "user_query": "What is the main manifestation of Liebenberg syndrome?",
    "llama-2-7b-chat-hf_response": "Liebenberg syndrome is a rare genetic disorder characterized by the following main manifestations:\n1. Distal myopathy: Muscle weakness and wasting, primarily affecting the muscles in the arms and legs.\n2. Spasticity: Muscle stiffness and spasms, which can lead to difficulty with movement and balance.\n3. Scoliosis: Curvature of the spine, which can lead to postural problems and difficulty with breathing.\n4. Neuropathy: Nerve damage, which can cause numbness, tingling, and pain in the hands and feet.\n5. Cognitive impairment: Difficulty with cognitive function, including memory, attention, and problem-solving.\n6. Seizures: Seizures are a common complication of Liebenberg syndrome, particularly in children.\n7. Vision problems: Visual impairment, including cataracts, glaucoma, and optic atrophy.\n8. Hearing loss: Hearing loss or deafness can occur in some individuals with Liebenberg syndrome.\n9. Sleep disturbances: Sleep disorders, such as sleep apnea and insomnia, can occur in individuals with Liebenberg syndrome.\n10. Autism spectrum disorder: Some individuals with Liebenberg syndrome may also have autism spectrum disorder, which can affect social interaction, communication, and behavior.\nIt is important to note that the severity and specific manifestations of Liebenberg syndrome can vary widely between individuals, and some individuals may have a more mild or severe form of the disorder. A comprehensive diagnostic evaluation and multidisciplinary care can help manage the symptoms and improve the quality of life for individuals with Liebenberg syndrome."
  },
  {
    "id": 3977,
    "user_query": "List orally bioavailable MPS1 kinase inhibitors",
    "llama-2-7b-chat-hf_response": "There are several orally bioavailable MPS1 kinase inhibitors that have been identified and developed for the treatment of various diseases, including cancer. Here are some examples:\n1. Vorinostat (Zolinza): Vorinostat is an oral histone deacetylase (HDAC) inhibitor that has been shown to inhibit MPS1 activity in various cell types, including cancer cells. It is approved for the treatment of cutaneous T-cell lymphoma.\n2. Romidepsin (Istodax): Romidepsin is an oral HDAC inhibitor that has been shown to inhibit MPS1 activity in various cell types, including cancer cells. It is approved for the treatment of cutaneous T-cell lymphoma.\n3. Panobinostat (Farydak): Panobinostat is an oral inhibitor of the enzyme PI3K (phosphatidylinositol 3-kinase), which is involved in the PI3K/AKT signaling pathway. This pathway is activated by MPS1 in various cell types, including cancer cells. Panobinostat is approved for the treatment of multiple myeloma.\n4. GDC-0980 (GDC-0980): GDC-0980 is an oral PI3K inhibitor that has been shown to inhibit MPS1 activity in various cell types, including cancer cells. It is currently being investigated for the treatment of various cancers, including breast, lung, and ovarian cancer.\n5. BAY 80-6946 (Bay 80-6946): BAY 80-6946 is an oral PI3K inhibitor that has been shown to inhibit MPS1 activity in various cell types, including cancer cells. It is currently being investigated for the treatment of various cancers, including breast, lung, and ovarian cancer.\n6. PI-103 (PI-103): PI-103 is an oral PI3K inhibitor that has been shown to inhibit MPS1 activity in various cell types, including cancer cells. It is currently being"
  },
  {
    "id": 4031,
    "user_query": "Was golimumab tested for diabetes?",
    "llama-2-7b-chat-hf_response": "Yes, golimumab has been studied for the treatment of various autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. However, it has not been specifically approved for the treatment of diabetes."
  },
  {
    "id": 4055,
    "user_query": "Is progeria caused by an autosomal recessive gene?",
    "llama-2-7b-chat-hf_response": "Yes, progeria, also known as Hutchinson-Gilford progeria syndrome (HGPS), is caused by an autosomal recessive mutation in the LMNA gene. The LMNA gene provides instructions for making a protein called lamin A, which is involved in the structure and maintenance of chromosomes. Mutations in the LMNA gene can lead to the production of a faulty lamin A protein, which accumulates in the nucleus of cells and disrupts normal cellular function, leading to the characteristic features of progeria, including accelerated aging and death."
  },
  {
    "id": 4082,
    "user_query": "What are common variants at 12q14 and 12q24 associated with?",
    "llama-2-7b-chat-hf_response": "Variants at chromosome 12q14 and 12q24 have been associated with several diseases and conditions, including:\n12q14:\n* Bipolar disorder: Variants in this region have been identified as risk factors for bipolar disorder.\n* Schizophrenia: Some studies have found an increased risk of schizophrenia in individuals with variants in this region.\n* Major depressive disorder: Some studies have found an increased risk of major depressive disorder in individuals with variants in this region.\n* Autism spectrum disorder: Some studies have found an increased risk of autism spectrum disorder in individuals with variants in this region.\n12q24:\n* Prostate cancer: Variants in this region have been identified as risk factors for prostate cancer.\n* Breast cancer: Some studies have found an increased risk of breast cancer in individuals with variants in this region.\n* Ovarian cancer: Some studies have found an increased risk of ovarian cancer in individuals with variants in this region.\n* Type 2 diabetes: Some studies have found an increased risk of type 2 diabetes in individuals with variants in this region.\nIt is important to note that the associations between these variants and disease risk are complex and may involve multiple genetic and environmental factors. More research is needed to fully understand the relationships between these variants and disease risk."
  },
  {
    "id": 4096,
    "user_query": "Which are the ligands of the Roundabout (Robo) receptors?",
    "llama-2-7b-chat-hf_response": "The ligands of the Roundabout (Robo) receptors are the Robo ligands, which include:\n1. Robo1 ligand (RALBP1): This ligand is a membrane-bound protein that binds to Robo1 and regulates its activity.\n2. Robo2 ligand (RALBP2): This ligand is also a membrane-bound protein that binds to Robo2 and regulates its activity.\n3. Robo3 ligand (RALBP3): This ligand is a secreted protein that binds to Robo3 and regulates its activity.\n4. Robo4 ligand (RALBP4): This ligand is a membrane-bound protein that binds to Robo4 and regulates its activity.\nThese ligands play a crucial role in regulating the activity of the Robo receptors and modulating the behavior of cells in various tissues, including the nervous system, immune system, and cancer cells."
  },
  {
    "id": 4112,
    "user_query": "Is there a role for TFII-I in megakaryopoiesis?",
    "llama-2-7b-chat-hf_response": "Yes, TFII-I plays a role in megakaryopoiesis. TFII-I is a transcription factor that is involved in the regulation of gene expression during megakaryocyte differentiation. It is required for the proper expression of genes involved in platelet function and platelet membrane protein synthesis. TFII-I is also important for the maintenance of platelet function and survival, and its dysregulation has been implicated in platelet disorders such as thrombocytopenia and platelet dysfunction."
  },
  {
    "id": 4145,
    "user_query": "Is atenolol metabolized by CYP2D6?",
    "llama-2-7b-chat-hf_response": "Yes, atenolol is metabolized by the cytochrome P450 enzyme CYP2D6. CYP2D6 is responsible for the metabolism of approximately 20-30% of drugs in clinical use today, including atenolol."
  },
  {
    "id": 4158,
    "user_query": "List versions of ExpansionHunter",
    "llama-2-7b-chat-hf_response": "ExpansionHunter is a tool used for detecting gene fusions in RNA-seq data. Here are some versions of ExpansionHunter:\n1. ExpansionHunter 1.0: This is the original version of ExpansionHunter, which was released in 2015.\n2. ExpansionHunter 2.0: This version was released in 2017 and includes several improvements over the original version, including improved sensitivity and specificity, as well as the ability to detect fusions in both tumor and normal samples.\n3. ExpansionHunter 3.0: This is the latest version of ExpansionHunter, which was released in 2020. It includes several new features, including the ability to detect fusions in single cells, and improved performance in detecting fusions in complex genomic regions.\n4. ExpansionHunter-Lite: This is a simplified version of ExpansionHunter that is designed for use with smaller datasets. It includes a reduced set of algorithms and is optimized for faster computation.\n5. ExpansionHunter-Pipeline: This is a version of ExpansionHunter that is integrated into a larger pipeline for genomic analysis. It includes tools for data preprocessing, fusion detection, and downstream analysis.\n6. ExpansionHunter-Cloud: This is a cloud-based version of ExpansionHunter that allows users to access the tool from any computer with an internet connection. It includes a web-based interface and is designed for use with large datasets.\n7. ExpansionHunter-Python: This is a Python package for ExpansionHunter that allows users to integrate the tool into their own pipelines and workflows. It includes a set of pre-built functions for performing fusion detection and analysis.\n8. ExpansionHunter-R: This is a version of ExpansionHunter for use with the R programming language. It includes a set of pre-built functions for performing fusion detection and analysis, as well as a user-friendly interface for interacting with the tool."
  },
  {
    "id": 4164,
    "user_query": "What is the role of Adamts18 in hormone receptor signaling?",
    "llama-2-7b-chat-hf_response": "Adamts18 (a disintegrin and metalloproteinase domain-containing protein 18) plays a role in regulating hormone receptor signaling by modulating the activity of the estrogen receptor (ER). Adamts18 can bind to the ER and inhibit its activity, thereby reducing the signaling response to estrogen. This can have implications for the regulation of various cellular processes, including cell growth, differentiation, and survival."
  },
  {
    "id": 4208,
    "user_query": "What is the mode of action of Thiazovivin?",
    "llama-2-7b-chat-hf_response": "Thiazovivin is a small molecule inhibitor of the histone acetyltransferase (HAT) enzyme p300. It works by binding to the p300 protein and preventing it from acetylating histones, which leads to the repression of gene transcription. Thiazovivin can be used to study the function of p300 in various cellular processes, including cell proliferation, differentiation, and survival, and it has also been investigated as a potential therapeutic agent for the treatment of cancer and other diseases."
  }
]